Other disorders of nervous system

G6_NEUROOTH

nervous system disease: A non-neoplastic or neoplastic disorder that affects the brain, spinal cord, or peripheral nerves.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G98, G99* Cause of death: ICD-10 — G98, G99* 2 out of 7 registries used, show all original rules.	2489
4. Check minimum number of events None	2489
5. Include endpoints None	2489
6. Filter based on genotype QC (FinnGen only)	2489

Control definitions (FinnGen only)

Control exclude: G6_OTHNEU

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	G6_NEUROOTH
CONTROL_EXCLUDE	G6_OTHNEU
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G98\|G99
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G98\|G99
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other disorders of nervous system based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	13637	6281	7307
Only index persons	12774	5937	6837
Unadjusted period prevalence (%)
Whole population	0.19	0.18	0.20
Only index persons	0.24	0.22	0.26
Median age at first event (years)
Whole population	58.90	59.38	58.44
Only index persons	58.38	58.76	58.05

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2489	1234	1255
Unadjusted period prevalence (%)	0.49	0.42	0.55
Median age at first event (years)	59.15	57.67	60.62

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2257: Matched controls
22570

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

27.8

323.0

473

213

ABC60

NOMESCO Finland

Decompression of cervical spinal cord

187.7

323.0

376

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

19.0

323.0

654

474

G99.2*M50.0

ICD-10 Finland

Cervical disc disorder with myelopathy

1698.0

323.0

523

N03AX16

ATC

pregabalin; oral

6.2

323.0

1164

3288

G99.2*M51.0

ICD-10 Finland

Lumbar and other intervertebral disc disorders with myelopathy

1208.6

323.0

313

G99.2*M47.1

ICD-10 Finland

Spondylogenic compression of spinal cord

8596.1

323.0

637

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

23.3

323.0

531

294

G99.2

ICD-10 Finland

Myelopathy in diseases classified elsewhere

962.8

323.0

398

M48.0

ICD-10 Finland

Spinal stenosis

11.4

323.0

1001

1479

G99.2*M47.9

ICD-10 Finland

Myelopathy in spondylosis

1163.9

317.4

303

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

53.7

315.0

377

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

14.6

293.1

523

457

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

10.0

251.4

549

706

N03AX12

ATC

gabapentin; oral

6.1

250.7

821

1931

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

5.5

205.9

726

1797

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

6.3

191.2

573

1148

N02AX02

ATC

tramadol; systemic, rectal

3.6

181.4

1391

6910

G99.2*M47.0

ICD-10 Finland

Anterior spinal and vertebral artery compression syndromes

+∞

160.3

152

WX408

NOMESCO Finland

General anesthesy, balanced

3.6

159.8

996

4055

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

5.2

154.7

547

1303

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

7.4

153.9

397

631

M47.9

ICD-10 Finland

Spondylosis, unspecified

10.9

148.2

298

310

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

8.0

144.1

352

512

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

5.2

143.5

502

1171

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

16.9

142.0

233

153

NAG41

NOMESCO Finland

Anterior fusion of cervical spine with fixation

46.5

133.4

164

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

17.8

129.7

208

128

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

20.8

128.7

195

102

N06AX21

ATC

duloxetine; oral

4.5

111.4

450

1192

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

7.7

108.9

268

387

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

8.7

106.1

241

306

L01

ICPC

Neck symptom/complaint

3.9

106.0

511

1586

ABC50

NOMESCO Finland

Decopression of cervical spinal canal and nerve roots

77.9

98.2

111

M03BX01

ATC

baclofen; systemic

16.3

97.4

161

106

G98

ICD-10 Finland

Other disorders of nervous system, not elsewhere classified

913.8

90.4

M54.5

ICD-10 Finland

Low back pain

2.6

88.8

912

4679

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

21.2

88.0

132

AA1AD

NOMESCO Finland

CT of head and brain

2.9

87.3

664

2838

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.6

87.1

851

4230

M50.3

ICD-10 Finland

Other cervical disc degeneration

9.2

82.1

178

207

G99.0*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic autonomic neuropathy

+∞

81.8

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

3.0

80.5

543

2127

N06AA09

ATC

amitriptyline; systemic

3.7

78.7

391

1217

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

13.2

78.5

141

113

M54.4

ICD-10 Finland

Lumbago with sciatica

3.0

77.8

534

2110

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.3

77.0

1213

7578

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

4.0

76.1

338

953

M03BX02

ATC

tizanidine; oral

2.3

75.9

1547

10900

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

20.1

75.6

115

G56.0

ICD-10 Finland

Carpal tunnel syndrome

3.2

75.0

448

1602

XKD06

NOMESCO Finland

Physiologic investigation of micturition

7.3

74.5

188

278

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

16.3

73.7

121

L28

ICPC

Limited function/disability (L)

3.0

71.5

475

1824

M54.1

ICD-10 Finland

Radiculopathy

6.4

71.3

198

334

M54.2

ICD-10 Finland

Cervicalgia

4.3

71.0

286

734

N02BE01

ATC

paracetamol; systemic, rectal

3.0

70.5

2023

16691

NA1AD

NOMESCO Finland

Cervical spine CT examination

6.0

68.5

201

364

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.2

67.9

1122

7004

N02AJ06

ATC

codeine and paracetamol; systemic

2.2

67.6

969

5665

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.8

67.4

515

2152

M50.0

ICD-10 Finland

Cervical disc disorder with myelopathy

146.5

67.3

G95.8

ICD-10 Finland

Other specified diseases of spinal cord

+∞

67.0

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

7.2

65.7

167

249

G99.0*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic autonomic neuropathy

+∞

63.8

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

7.4

63.0

157

227

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.9

62.9

445

1765

L86

ICPC

Back syndrome with radiating pain

4.5

61.8

233

558

N02AA05

ATC

oxycodone; systemic

2.8

61.5

456

1861

XKC03

NOMESCO Finland

Water cystometry

6.1

61.0

174

303

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

5.6

60.1

185

354

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.9

59.8

270

764

L03

ICPC

Low back symptom/complaint

2.4

59.2

648

3276

M79.6

ICD-10 Finland

Pain in limb

2.1

57.5

891

5281

SPAT1262

SPAT

Handing over of treatment supplies

2.5

56.6

535

2498

A02BC02

ATC

pantoprazole; systemic

2.1

56.4

1547

11553

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

5.8

56.2

168

310

M54.9

ICD-10 Finland

Dorsalgia, unspecified

3.1

55.8

344

1237

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.7

55.7

268

799

M03BC01

ATC

orphenadrine (citrate); systemic

2.3

54.9

629

3230

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

8.0

54.4

127

166

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

6.8

53.8

141

219

M53.1

ICD-10 Finland

Cervicobrachial syndrome

3.1

53.2

328

1177

T91.3

ICD-10 Finland

Sequelae of injury of spinal cord

57.9

52.8

M01AH05

ATC

etoricoxib; oral

2.0

52.4

1417

10359

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

19.2

52.1

N03AE01

ATC

clonazepam; systemic

4.1

51.2

214

563

WX110

NOMESCO Finland

Local anesthesy

2.0

51.2

1583

12134

SPAT1229

SPAT

Assessment of need for aid

3.5

51.1

265

837

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

16.1

49.5

S18

ICPC

Laceration/cut

1.9

47.9

1034

6846

WX402

NOMESCO Finland

General anaesthesia

2.4

47.8

475

2250

G992, M472

ICD-10 Finland

+∞

47.0

UKC02

NOMESCO Finland

Cystoscopy

2.4

45.9

461

2193

G82.2

ICD-10 Finland

Paraplegia, unspecified

32.4

45.6

N03AX09

ATC

lamotrigine; oral

4.9

45.2

155

334

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.0

45.1

729

4288

G992, M480

ICD-10 Finland

+∞

44.9

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

9.3

44.8

106

L83

ICPC

Neck syndrome

13.4

44.7

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

7.6

44.6

107

146

ABC63

NOMESCO Finland

Decompression of thoracic spinal cord

446.2

44.4

J01FF01

ATC

clindamycin; systemic

2.0

43.8

696

4060

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

12.0

43.6

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

5.7

43.6

130

239

M50.9

ICD-10 Finland

Cervical disc disorder, unspecified

15.5

43.4

SPAT1153

SPAT

Removal of sutures

2.0

43.2

808

5013

SPAT1263

SPAT

Sampling

1.9

43.1

976

6491

NAG42

NOMESCO Finland

Posterior fusion of cervical spine with or without fixation

39.5

42.9

M47.82

ICD-10 Finland

Other spondylosis, cervical region

4.4

42.7

163

392

M43.1

ICD-10 Finland

Spondylolisthesis

4.5

42.3

159

377

R20.2

ICD-10 Finland

Paraesthesia of skin

3.6

42.2

204

606

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

149.5

41.9

C03CA01

ATC

furosemide; systemic

2.0

41.8

667

3880

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.2

41.6

242

827

ABC10

NOMESCO Finland

Microsurgical excision of cervical intervertebral disc displacement

32.5

41.1

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

12.7

41.0

N06AX16

ATC

venlafaxine; oral

2.5

41.0

362

1601

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.6

40.6

197

587

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

40.3

700

4197

SPAT1215

SPAT

Assessment of need for medical rehabilitation

4.1

39.1

159

406

A02BC05

ATC

esomeprazole; systemic

1.8

38.6

951

6432

J01MA02

ATC

ciprofloxacin; systemic

1.8

38.1

916

6134

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

11.1

37.9

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

6.0

37.8

108

188

X59

ICD-10 Finland

Exposure to unspecified factor

2.1

37.4

474

2487

R42

ICD-10 Finland

Dizziness and giddiness

2.1

37.2

492

2631

S97

ICPC

Chronic ulcer skin

3.6

37.0

175

510

Z01.8

ICD-10 Finland

Other specified special examinations

2.0

36.8

538

2997

N06AA10

ATC

nortriptyline; systemic

6.5

36.6

157

G992M

ICD-10 Finland

+∞

36.6

NF1AA

NOMESCO Finland

Hip X-ray examination

2.8

36.3

251

958

J01DB01

ATC

cefalexin; oral

1.9

36.2

1827

15468

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

36.2

930

6338

TPH04

NOMESCO Finland

Cathetrisation of vein

2.0

36.1

524

2905

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.6

36.0

287

1195

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

5.5

35.4

108

204

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

11.7

35.3

SPAT1216

SPAT

Assessment of functional ability

2.3

34.9

380

1856

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

4.4

34.8

133

320

N06AX11

ATC

mirtazapine; oral

1.9

34.8

726

4599

103

Kela drug reimbursment

Diabetes, insulin-treated

1.9

34.4

642

3905

M01AH02

ATC

rofecoxib; oral

2.3

34.2

358

1715

R1250

NOMESCO Finland

Evaluation of functional capability

5.8

34.0

177

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.0

33.9

213

764

H02AB06

ATC

prednisolone; systemic

1.7

33.9

1050

7536

R06.0

ICD-10 Finland

Dyspnoea

1.9

33.8

576

3385

J01MA12

ATC

levofloxacin; systemic

2.1

33.7

471

2563

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

5.3

33.7

106

208

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

4.3

33.6

131

322

N05CF01

ATC

zopiclone; oral

1.8

33.6

753

4873

N18

ICPC

Paralysis/weakness

7.4

33.4

113

A28

ICPC

Limited function/disability NOS

2.3

33.3

348

1664

A06AD11

ATC

lactulose; oral

2.3

33.2

351

1686

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.9

33.1

593

3549

XKD03

NOMESCO Finland

Urethral pressure profilometry

5.0

33.0

110

230

M01AB05

ATC

diclofenac; systemic, rectal

1.7

33.0

1516

12192

M25.5

ICD-10 Finland

Pain in joint

1.9

33.0

647

3995

R52.2

ICD-10 Finland

Other chronic pain

4.4

32.9

124

295

R51.80

ICD-10 Finland

Headache

2.3

32.7

325

1515

G47.3

ICD-10 Finland

Sleep apnoea

2.0

32.6

536

3101

G992, M511

ICD-10 Finland

+∞

32.4

A01

ICPC

Pain general/multiple sites

2.9

32.3

213

787

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

12.6

32.3

ABC53

NOMESCO Finland

Decompression of thoracic spinal canal and nerve roots

115.0

31.7

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

22.9

31.4

ACC51

NOMESCO Finland

Release of median nerve

2.8

31.3

215

815

R4120

NOMESCO Finland

Occupational therapy

3.0

31.3

191

672

R4110

NOMESCO Finland

Physiotherapy

1.8

31.3

640

3998

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

7.0

31.3

117

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.2

31.3

343

1675

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.9

31.1

590

3586

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.4

30.9

299

1374

XX2CT

NOMESCO Finland

Other injection with CT guidance

29.8

30.8

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

111.6

30.7

NA1CM

NOMESCO Finland

Cervical spine extensive MRI examination with 3 Tesla magnet

26.7

30.6

M54.3

ICD-10 Finland

Sciatica

3.1

30.3

179

615

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

6.0

30.2

146

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.8

30.1

210

805

M03BC51

ATC

orphenadrine, combinations; systemic

1.8

30.0

653

4153

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.8

29.9

200

746

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.6

29.7

225

906

G56.2

ICD-10 Finland

Lesion of ulnar nerve

4.0

29.5

121

312

G44.2

ICD-10 Finland

Tension-type headache

2.3

29.4

303

1431

R33

ICD-10 Finland

Retention of urine

2.7

29.4

219

873

L89

ICD-10 Finland

Decubitus ulcer and pressure area

6.7

29.3

117

G54.0

ICD-10 Finland

Brachial plexus disorders

5.9

29.2

148

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.4

29.2

150

466

TPH07

NOMESCO Finland

Cathetrisation of artery

2.4

28.9

273

1236

Z50.1

ICD-10 Finland

Other physical therapy

3.0

28.9

175

611

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.3

28.8

278

1274

SPAT1301

SPAT

No procedures

1.8

28.5

702

4624

WX704

NOMESCO Finland

Intubation

2.7

28.4

206

807

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.9

28.3

507

3008

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.1

28.0

348

1790

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.8

27.9

187

696

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.2

27.8

156

515

I10

ICD-10 Finland

Essential (primary) hypertension

1.6

27.7

1290

10143

N02AC04

ATC

dextropropoxyphene; oral

3.7

27.7

126

355

M51.0

ICD-10 Finland

Lumbar and other intervertebral disc disorders with myelopathy

35.5

27.4

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

27.4

744

5038

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.7

27.3

204

813

A02BC01

ATC

omeprazole; systemic

1.8

27.3

638

4126

M54

ICD-10 Finland

Dorsalgia

2.3

27.2

272

1266

ABB00

NOMESCO Finland

Excision of lesion of spinal canal

24.1

27.0

A10AE04

ATC

insulin glargine; parenteral

2.4

26.9

248

1108

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.3

26.8

275

1295

R13

ICD-10 Finland

Dysphagia

2.9

26.8

177

653

A46

ICD-10 Finland

Erysipelas

2.1

26.8

347

1812

M01AE03

ATC

ketoprofen; systemic, rectal

1.7

26.5

863

6136

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.9

26.5

167

599

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

6.9

26.5

100

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.8

26.3

532

3279

G99.0

ICD-10 Finland

Autonomic neuropathy in endocrine and metabolic diseases

+∞

26.1

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

+∞

26.1

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.1

25.9

317

1618

R07.4

ICD-10 Finland

Chest pain, unspecified

1.8

25.9

607

3918

M79.1

ICD-10 Finland

Myalgia

2.1

25.8

304

1525

J01DA01

ATC

[U] cefalexin; systemic

1.6

25.8

1351

10859

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.7

25.8

193

768

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.5

25.7

218

930

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.2

25.7

297

1476

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

25.6

481

2886

M48.9

ICD-10 Finland

Spondylopathy, unspecified

14.7

25.2

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.3

25.0

258

1216

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

25.0

538

3372

XKD00

NOMESCO Finland

Uroflowmetry

1.9

25.0

401

2273

M01AH01

ATC

celecoxib; oral (coxibs)

1.9

24.9

441

2592

NAG65

NOMESCO Finland

Anterior and posterior fusion of lumbar spine

17.2

24.9

R60.0

ICD-10 Finland

Localized oedema

2.2

24.9

264

1262

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

23.7

24.8

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

10.2

24.8

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.8

24.7

491

2996

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.0

24.7

363

1990

TKC20

NOMESCO Finland

Catheterisation of bladder

2.6

24.7

191

776

M54.6

ICD-10 Finland

Pain in thoracic spine

2.8

24.6

166

623

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

3.7

24.5

110

307

UJF32

NOMESCO Finland

Coloscopy

1.7

24.3

585

3791

N05BA01

ATC

diazepam; systemic, rectal

2.1

24.3

318

1665

L02

ICPC

Back symptom/complaint

2.4

24.2

215

941

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

9.8

23.8

N06AB04

ATC

citalopram; systemic

1.8

23.6

477

2921

L13

ICPC

Hip symptom/complaint

1.9

23.6

362

2015

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

6.6

23.6

G95.9

ICD-10 Finland

Disease of spinal cord, unspecified

126.3

23.6

G82.5

ICD-10 Finland

Tetraplegia, unspecified

126.3

23.6

T90

ICPC

Diabetes non-insulin dependent

1.8

23.6

527

3335

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

9.6

23.5

L08

ICPC

Shoulder symptom/complaint

1.8

23.5

447

2684

M01AX17

ATC

nimesulide; oral

1.7

23.4

570

3702

L12

ICPC

Hand/finger symptom/complaint

2.0

23.3

324

1737

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

3.6

23.2

108

311

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.1

23.2

295

1523

N31.1

ICD-10 Finland

Reflex neuropathic bladder, not elsewhere classified

11.5

23.2

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.5

23.1

185

766

L17

ICPC

Foot/toe symptom/complaint

1.7

23.0

553

3571

A10AA01

ATC

4.2

22.8

220

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

4.4

22.8

192

M01AE02

ATC

naproxen; oral, rectal

1.6

22.7

1212

9639

S14.0

ICD-10 Finland

Concussion and oedema of cervical spinal cord

40.5

22.7

G82.1

ICD-10 Finland

Spastic paraplegia

232.2

22.7

G55.2

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

10.9

22.6

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

22.4

1069

8268

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.1

22.2

284

1471

NAG53

NOMESCO Finland

Posterior or lateral fusion of thoracic spine with fixation, more than 3 vertebraea

24.1

22.2

ZZH40

NOMESCO Finland

Substitute of bone

8.9

22.1

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.9

22.1

141

509

A10AA02

ATC

3.6

22.0

103

299

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.1

21.8

254

1265

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.0

21.7

287

1504

SPAT1254

SPAT

Administration of medicine

2.0

21.7

318

1736

N04BC05

ATC

pramipexole; oral

2.5

21.7

182

772

N81

ICPC

Injury nervous system other

18.6

21.7

NAG52

NOMESCO Finland

Posterior or lateral fusion of thoracic spine with fixation, 2-3 vertebraea

43.8

21.4

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

21.4

896

6692

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.1

21.3

119

394

R52.9

ICD-10 Finland

Pain, unspecified

2.3

21.3

201

905

SPAT1231

SPAT

Assessment of adjustments needed in living environment

4.9

21.3

146

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

21.2

306

1659

A02BC03

ATC

lansoprazole; oral

1.6

21.2

632

4325

N30.0

ICD-10 Finland

Acute cystitis

2.0

21.1

284

1499

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

3.4

21.1

105

320

M01AB55

ATC

diclofenac, combinations; oral

2.4

21.0

188

823

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.5

20.9

177

755

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.4

20.9

103

311

G95.0

ICD-10 Finland

Syringomyelia and syringobulbia

+∞

20.9

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

20.7

816

5988

TAB00

NOMESCO Finland

Lumbar puncture

3.1

20.6

114

375

C08CA01

ATC

amlodipine; oral

1.6

20.6

774

5618

N03AF01

ATC

carbamazepine; oral, rectal

2.9

20.6

133

485

AWB00

NOMESCO Finland

Reoperation for superficial infection in surgery of the nervous system

30.3

20.6

N28

ICPC

Limited function/disability (N)

6.4

20.5

N05BA04

ATC

oxazepam; oral

1.7

20.5

515

3355

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

20.5

190

848

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

20.4

408

2482

R53

ICD-10 Finland

Malaise and fatigue

1.8

20.3

399

2413

M01AB51

ATC

indometacin, combinations; oral, rectal

3.9

20.3

225

A10AE05

ATC

insulin detemir; parenteral

2.7

20.2

147

576

R11

ICD-10 Finland

Nausea and vomiting

2.4

20.2

176

763

AWE00

NOMESCO Finland

Reoperation for deep heamorrhage in surgery of the nervous system

32.8

20.2

M70.6

ICD-10 Finland

Trochanteric bursitis

2.0

20.2

269

1411

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

20.2

681

4803

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

3.3

20.1

104

326

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

3.2

20.1

109

354

M41.9

ICD-10 Finland

Scoliosis, unspecified

6.9

20.0

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

20.0

392

2367

L14

ICPC

Leg/thigh symptom/complaint

2.4

20.0

179

786

NA1DG

NOMESCO Finland

Cervical spine very extensive MRI examination with high intensity magnet

21.0

19.9

ACC53

NOMESCO Finland

Release of ulnar nerve

5.2

19.9

122

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.2

19.9

204

957

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

6.8

19.9

R52.1

ICD-10 Finland

Chronic intractable pain

7.7

19.9

M01AC06

ATC

meloxicam; systemic, rectal

1.6

19.8

800

5890

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.9

19.8

310

1732

M43.0

ICD-10 Finland

Spondylolysis

4.7

19.8

149

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.3

19.7

188

850

ABC21

NOMESCO Finland

Anterior decompression of cervical spine with insertion of interbody fixating implant

74.1

19.7

ABC66

NOMESCO Finland

Decompression of lumbal spinal channel

13.3

19.7

M50.2

ICD-10 Finland

Other cervical disc displacement

19.6

19.5

A10BA02

ATC

metformin; oral

1.6

19.5

595

4083

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

3.9

19.5

213

H3603, E103

ICD-10 Finland

7.4

19.5

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.9

19.4

209

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

19.4

253

1317

WX725

NOMESCO Finland

Noninvasive ventilation

2.8

19.3

130

486

N05AH04

ATC

quetiapine; oral

1.9

19.2

327

1881

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

6.7

19.2

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.9

19.1

121

437

K59.09

ICD-10 Finland

Constipation, unspecified

2.6

19.0

144

578

B01AC04

ATC

clopidogrel; oral

1.9

19.0

307

1732

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

7.4

19.0

NAU20

NOMESCO Finland

Removal of internal fixation device from spine or neck

14.9

18.9

M86.6

ICD-10 Finland

Other chronic osteomyelitis

16.0

18.8

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

3.9

18.8

205

M02AA07

ATC

piroxicam; topical

1.5

18.7

782

5785

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.0

18.7

112

388

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

3.2

18.7

311

P01AB01

ATC

metronidazole; oral, rectal

1.5

18.7

807

6014

9211

FHL

Exploration or removal of diskusprolapse

4.0

18.6

197

G95.2

ICD-10 Finland

Cord compression, unspecified

100.9

18.6

N06AB10

ATC

escitalopram; oral

1.8

18.5

390

2401

T89

ICPC

Diabetes insulin dependent

3.1

18.5

103

342

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

4.0

18.4

189

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.5

18.4

147

609

NA3CM

NOMESCO Finland

Lumbar spine extensive MRI examination with 3 Tesla magnet

19.5

18.2

G04BD12

ATC

mirabegron; oral

2.0

18.0

231

1192

U04

ICPC

Incontinence urine

2.9

18.0

110

388

W19

ICD-10 Finland

Unspecified fall

2.1

18.0

214

1071

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.1

18.0

220

1112

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

18.0

272

1499

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.2

17.9

186

875

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.3

17.9

172

782

J02AC01

ATC

fluconazole; systemic

1.5

17.9

761

5640

SPAT1310

SPAT

Counselling related to known health issue

1.6

17.9

658

4711

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

17.8

478

3158

TAB20

NOMESCO Finland

Epidural puncture

7.4

17.7

E66.01

ICD-10 Finland

Obesity due to excess calories

2.3

17.6

172

789

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

17.6

578

4023

J01CA04

ATC

amoxicillin; systemic

1.5

17.5

1672

14697

M50.8

ICD-10 Finland

Other cervical disc disorders

10.8

17.4

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

29.0

17.4

ABB10

NOMESCO Finland

Resection of lesion of spinal canal

29.0

17.4

C07AB07

ATC

bisoprolol; oral

1.5

17.4

988

7783

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

3.4

17.4

251

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

17.4

369

2276

R4180

NOMESCO Finland

Podiatric therapy

6.8

17.3

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

3.2

17.3

296

SPAT1211

SPAT

Application of soft bandage

2.1

17.3

211

1069

H04AA01

ATC

glucagon; nasal, parenteral

4.2

17.2

162

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.2

17.0

175

823

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.8

16.9

328

1966

G55.1*M51.9

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)

6.6

16.9

B01AB05

ATC

enoxaparin; parenteral

1.5

16.8

642

4623

ZXC95

NOMESCO Finland

Use of surgical navigator

5.7

16.8

R35

ICD-10 Finland

Polyuria

2.3

16.7

155

691

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.3

16.7

155

692

G992, M501

ICD-10 Finland

+∞

16.7

G83.4

ICD-10 Finland

Cauda equina syndrome

12.8

16.6

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.3

16.5

159

724

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

16.4

970

7673

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

6.1

16.4

SPAT1312

SPAT

General health counselling

1.5

16.3

630

4545

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

7.8

16.3

JN3AD

NOMESCO Finland

Abdominal CT examination

2.2

16.3

173

824

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.8

16.3

302

1780

N07BC02

ATC

methadone; systemic

11.2

16.2

M01AE51

ATC

ibuprofen, combinations; systemic

4.2

16.2

152

X58

ICD-10 Finland

Exposure to other specified factors

1.8

16.2

301

1777

NA3SA

NOMESCO Finland

Lumbar spine X-ray examination in standing position

6.8

16.0

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

3.0

16.0

324

R03AC02

ATC

salbutamol; inhalant

1.4

16.0

1052

8484

G55.1

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders

6.5

16.0

N05CD07

ATC

temazepam; oral

1.9

16.0

268

1528

TAC99

NOMESCO Finland

Other blockade for chronic pain

9.0

15.9

R5140

NOMESCO Finland

Monitoring the use of the aid

1.9

15.8

240

1321

D43.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Spinal cord

60.4

15.8

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

15.7

169

810

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.5

15.7

129

541

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.8

15.7

299

1780

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.4

15.7

234

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

7.6

15.6

N29

ICPC

Neurological sympt/complt other

4.3

15.6

134

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.9

15.6

357

L15

ICPC

Knee symptom/complaint

1.6

15.5

418

2749

NA3CF

NOMESCO Finland

Lumbar spine extensive MRI examination with median intensity magnet

11.8

15.5

S14.1

ICD-10 Finland

Other and unspecified injuries of cervical spinal cord

161.0

15.5

M47.0

ICD-10 Finland

Anterior spinal and vertebral artery compression syndromes

161.0

15.5

M79.7

ICD-10 Finland

Fibromyalgia

3.2

15.5

269

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.1

15.5

176

864

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

15.4

311

1881

R07.3

ICD-10 Finland

Other chest pain

2.0

15.4

199

1028

J01EA01

ATC

trimethoprim; systemic

1.6

15.4

475

3240

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

6.6

15.4

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

5.9

15.3

S06.0

ICD-10 Finland

Concussion

2.0

15.2

210

1116

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

15.2

1425

12257

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.8

15.1

254

1449

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.2

15.1

157

741

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

15.1

613

4460

G56.4

ICD-10 Finland

Causalgia

11.9

15.0

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

4.1

15.0

144

ZSA00

NOMESCO Finland

Procedure related to previous procedure classified in chapter A

14.0

15.0

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.1

15.0

179

896

N31.8

ICD-10 Finland

Other neuromuscular dysfunction of bladder

10.9

15.0

E66.00

ICD-10 Finland

Metabolic syndrome

2.4

14.9

133

583

NA2AD

NOMESCO Finland

Thoracic spine CT examination

7.7

14.9

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

14.9

358

2283

R55

ICD-10 Finland

Syncope and collapse

1.9

14.8

218

1185

A02BA02

ATC

ranitidine; systemic

1.6

14.7

410

2721

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

2.2

14.7

155

737

K59.0

ICD-10 Finland

Constipation

2.5

14.7

120

504

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.0

14.6

183

934

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.6

14.6

183

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

+∞

14.6

ABD40

NOMESCO Finland

Implantation of spinal injection device

+∞

14.6

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.3

14.5

131

579

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.4

14.5

128

559

ZXA00

NOMESCO Finland

Right side

1.5

14.4

567

4085

J01AA02

ATC

doxycycline; systemic

1.5

14.4

1652

14691

Z01.9

ICD-10 Finland

Special examination, unspecified

2.3

14.4

132

587

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

3.2

14.3

240

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.9

14.3

151

H3600, E103

ICD-10 Finland

5.5

14.2

H25.8

ICD-10 Finland

Other senile cataract

1.9

14.2

219

1212

WX002

NOMESCO Finland

Sedation and analgesia

1.6

14.2

430

2914

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

3.5

14.2

193

C01DA14

ATC

isosorbide mononitrate; oral

1.7

14.1

293

1789

ZXA10

NOMESCO Finland

Bilateral

1.6

14.0

376

2467

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.6

14.0

405

2711

J01FA06

ATC

roxithromycin; oral

1.4

14.0

809

6311

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

3.8

13.8

151

R51

ICD-10 Finland

Headache

2.5

13.8

105

425

WX882

NOMESCO Finland

High dependency care

3.2

13.7

225

S29

ICPC

Skin symptom/complaint other

1.7

13.7

342

2197

J01FA09

ATC

clarithromycin; systemic

1.5

13.7

622

4614

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.8

13.7

328

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.4

13.7

1118

9285

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

13.7

548

3957

G04CA02

ATC

tamsulosin; oral

1.5

13.7

474

3312

H02AB04

ATC

methylprednisolone; systemic

1.7

13.6

306

1909

M01AE01

ATC

ibuprofen; systemic, rectal

1.6

13.6

1914

17631

205

Kela drug reimbursment

Chronic hypertension

1.5

13.6

563

4096

A10BH01

ATC

sitagliptin; oral

1.9

13.6

201

1093

NA1BM

NOMESCO Finland

Cervical spine MRI examination with 3 Tesla magnet

14.8

13.6

9212

FHL

Other posterior root decompression surgery (eg laminectomy, Gill)

8.0

13.6

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

+∞

13.6

G90.2

ICD-10 Finland

Horner syndrome

+∞

13.6

NHQ40

NOMESCO Finland

Amputation of toe

4.1

13.5

129

R15

ICD-10 Finland

Faecal incontinence

3.2

13.5

217

NA1BG

SPAT

7.5

13.4

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.7

13.4

333

G45.3

ICD-10 Finland

Amaurosis fugax

18.3

13.4

M50

ICD-10 Finland

Cervical disc disorders

7.0

13.3

D32.1

ICD-10 Finland

Benign neoplasm: Spinal meninges

13.9

13.2

ZZH31

NOMESCO Finland

Bone allograft, small pieces

6.1

13.2

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

13.1

280

1721

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

13.1

455

3179

SPAT1260

SPAT

Consultation of another employee

1.6

13.0

365

2420

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

13.0

562

4121

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.4

13.0

109

465

N32.83

ICD-10 Finland

Nozzle synergy in the bladder neck

10.1

13.0

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

3.2

12.9

208

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.0

12.9

158

802

G04BD08

ATC

solifenacin; oral

2.1

12.9

151

753

A01AB09

ATC

miconazole; local oral

2.0

12.8

176

934

L84

ICPC

Back syndrome without radiat pain

2.5

12.8

404

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.7

12.8

156

L29

ICPC

Musculoskeletal sympt/complt other

2.0

12.8

161

826

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

3.5

12.8

167

Z02.7

ICD-10 Finland

Issue of medical certificate

2.3

12.8

122

556

N03AF02

ATC

oxcarbazepine; oral

3.0

12.7

238

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

12.7

322

2077

C10AA05

ATC

atorvastatin; oral

1.4

12.7

763

5970

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

4.6

12.7

SPAT1167

SPAT

Insertion of urinary catheter

2.8

12.6

285

R60.9

ICD-10 Finland

Oedema, unspecified

2.5

12.6

103

431

ABD99

NOMESCO Finland

Other operation on spinal cord or nerve for pain or impaired function

15.5

12.6

A10BH05

ATC

linagliptin; oral

2.5

12.6

101

421

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

7.9

12.6

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.1

12.6

149

747

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

12.5

216

1240

NF1DA

NOMESCO Finland

X-ray of hips

3.2

12.5

202

G91.0

ICD-10 Finland

Communicating hydrocephalus

+∞

12.5

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.9

12.5

190

1044

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

24.4

12.5

J37.0

ICD-10 Finland

Chronic laryngitis

2.9

12.5

253

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

6.3

12.4

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

12.4

456

3224

Z01.2

ICD-10 Finland

Dental examination

1.4

12.4

785

6189

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.1

12.4

143

709

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.6

12.3

151

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

3.6

12.3

151

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.1

12.3

221

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.9

12.3

261

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.4

12.3

105

452

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.8

12.3

230

1360

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

3.6

12.3

157

M41.5

ICD-10 Finland

Other secondary scoliosis

14.4

12.3

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

4.8

12.2

M54.8

ICD-10 Finland

Other dorsalgia

2.6

12.2

345

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.2

12.2

122

565

G04CA01

ATC

alfuzosin; oral

1.7

12.2

252

1534

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

6.4

12.1

H02AB07

ATC

prednisone; oral

1.7

12.1

296

1887

SPAT1255

SPAT

Intravenous administration of medicine

2.1

12.1

143

715

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.1

12.1

131

630

WZA90

NOMESCO Finland

Other doctors statement

1.5

12.1

449

3178

PA7BD

NOMESCO Finland

CT angiography of neck and brain

4.6

12.1

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

3.2

12.0

197

J01MA14

ATC

moxifloxacin; systemic

1.9

11.9

190

1064

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.8

11.9

130

R50.9

ICD-10 Finland

Fever, unspecified

1.7

11.9

272

1702

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.4

11.9

409

TKC22

NOMESCO Finland

Catheterisation instruction

3.2

11.9

199

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

11.9

391

2693

WX892

NOMESCO Finland

Monitored bed care

2.0

11.8

160

845

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.2

11.8

122

575

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

8.4

11.8

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.0

11.8

155

808

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

11.7

192

1085

M19.9

ICD-10 Finland

Arthrosis, unspecified

2.6

11.7

342

WX290

NOMESCO Finland

Other blockade of nerve

1.4

11.7

827

6634

M77.1

ICD-10 Finland

Lateral epicondylitis

2.0

11.7

146

745

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

11.7

262

1633

N30.9

ICD-10 Finland

Cystitis, unspecified

2.3

11.6

103

451

M53.2

ICD-10 Finland

Spinal instabilities

6.0

11.6

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.4

11.6

1130

9560

R03BB04

ATC

tiotropium bromide; inhalant

1.8

11.6

210

1224

G82.0

ICD-10 Finland

Flaccid paraplegia

65.3

11.6

R5599

NOMESCO Finland

Other rehabilitation service

3.0

11.6

230

ABC04

NOMESCO Finland

Percutaneous endoscopic discectomy for thoracic intervertebral disc displacement

+∞

11.5

N30.1

ICD-10 Finland

Interstitial cystitis (chronic)

4.8

11.5

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.4

11.4

418

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

3.7

11.4

136

J01CA08

ATC

pivmecillinam; oral

1.4

11.3

672

5219

C10AA01

ATC

simvastatin; oral

1.4

11.3

865

7019

R39.1

ICD-10 Finland

Other difficulties with micturition

2.7

11.3

288

NJ3NA

NOMESCO Finland

Measurement of difference in extremity lengty with X-ray

3.6

11.3

142

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

4.6

11.3

E66.8

ICD-10 Finland

Other obesity

2.3

11.2

106

480

N18.8

ICD-10 Finland

Other chronic renal failure

2.9

11.2

230

SPAT1104

SPAT

Monitoring of emergency patient

2.0

11.2

140

715

ZXA05

NOMESCO Finland

Left side

1.5

11.2

509

3757

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.4

11.2

159

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.8

11.1

261

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.4

11.1

1031

8632

F34.1

ICD-10 Finland

Dysthymia

2.7

11.1

295

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

11.1

411

2902

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.3

11.1

103

464

SPAT1097

SPAT

Recording of ECG

1.6

11.1

301

1975

R03BA05

ATC

fluticasone; inhalant

1.6

11.0

344

2335

D17

ICPC

Incontinence of bowel

6.1

11.0

R02

ICPC

Shortness of breath/dyspnoea

1.7

10.9

233

1431

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

10.9

170

941

M40.1

ICD-10 Finland

Other secondary kyphosis

43.5

10.9

J01FA10

ATC

azithromycin; systemic

1.4

10.9

1108

9399

D12

ICPC

Constipation

2.6

10.9

293

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

10.9

1239

10702

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

5.3

10.9

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.6

10.9

131

R52.0

ICD-10 Finland

Acute pain

2.9

10.9

230

9201

FHL

Anterior decompression surgery (also includes dees)

12.0

10.8

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

10.8

719

5685

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.2

10.8

180

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

4.0

10.8

107

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

10.8

650

5056

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.7

10.7

265

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.4

10.7

522

3902

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

10.7

192

1120

NAW00

NOMESCO Finland

Repair of wound dehiscence in surgery of spine or neck

21.6

10.7

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.9

10.7

147

783

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.8

10.6

244

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.6

10.6

292

K02.1

ICD-10 Finland

Caries of dentine

1.3

10.6

1089

9235

NA1BD

NOMESCO Finland

Extensive cervical spine CT examination

60.3

10.6

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.9

10.6

150

804

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.1

10.6

125

624

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.8

10.6

185

1067

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.8

10.5

246

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

10.5

785

6326

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

10.5

197

1161

Z71.8

ICD-10 Finland

Other specified counselling

1.5

10.5

428

3084

NBG10

NOMESCO Finland

Acromioplastia

2.7

10.5

271

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.7

10.5

207

1244

M04AA01

ATC

allopurinol; systemic

1.6

10.5

258

1649

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

10.4

135

701

L16

ICPC

Ankle symptom/complaint

1.8

10.4

191

1118

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

2.3

10.4

402

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

5.2

10.4

ABC13

NOMESCO Finland

Microsurgical excision of thoracic intervertebral disc displacement

110.5

10.4

G992, D321

ICD-10 Finland

+∞

10.4

N05CF02

ATC

zolpidem; oral

1.5

10.4

337

2304

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

3.5

10.4

136

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

4.4

10.4

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

10.4

311

2092

NAG99

NOMESCO Finland

Other excision, reconstruction or fusion of joints of spine, unspecified

32.7

10.3

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.6

10.3

127

M01AX05

ATC

glucosamine; oral

1.5

10.3

393

2793

E10

ICD-10 Finland

Type 1 diabetes mellitus

3.5

10.2

138

EBA10

NOMESCO Finland

Surgical removal of tooth

1.8

10.2

191

1129

G04BD04

ATC

oxybutynin; oral, transdermal

2.1

10.2

111

537

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.8

10.2

113

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

2.1

10.2

111

538

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

3.2

10.2

166

SPAT1325

SPAT

Vaccination

1.4

10.1

653

5127

R01AD08

ATC

fluticasone; nasal

1.4

10.1

533

4036

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

4.8

10.1

R06AE07

ATC

cetirizine; oral

1.4

10.0

820

6693

R32

ICD-10 Finland

Unspecified urinary incontinence

2.9

10.0

207

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.9

10.0

138

736

AB3CB

NOMESCO Finland

Lumbar myelography

40.2

10.0

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.4

10.0

372

M01AB01

ATC

indometacin; systemic, rectal

1.8

9.9

166

946

NG2AA

NOMESCO Finland

Patella X-ray examination

2.6

9.9

272

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

3.2

9.9

158

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.4

9.9

374

SPAT1172

SPAT

Guidance concerning hydration

3.3

9.9

153

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.0

9.9

130

678

25002

ICD-8 Finland

Diabetes mellitus, Retinopathia diabetica

12.2

9.8

A04

ICPC

Weakness/tiredness general

1.7

9.8

222

1383

G81.9

ICD-10 Finland

Hemiplegia, unspecified

5.2

9.8

WX213

NOMESCO Finland

Lower leg blockade

5.4

9.8

M99.3

ICD-10 Finland

Osseous stenosis of neural canal

8.8

9.8

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.0

9.8

124

641

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.8

9.8

162

919

R03DC03

ATC

montelukast; oral

1.6

9.7

289

1938

N07BA03

ATC

varenicline; oral

2.1

9.7

105

507

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.8

9.7

179

1051

C07AB02

ATC

metoprolol; systemic

1.5

9.7

386

2763

U07

ICPC

Urine symptom/complaint other

2.0

9.7

118

597

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

2.7

9.7

247

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

6.8

9.6

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.7

9.6

187

1119

NA2DG

NOMESCO Finland

Thoracal spine very extensive MRI examination with high intensity magnet

15.1

9.5

J01CF05

ATC

flucloxacillin; systemic

2.3

9.5

362

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.9

9.5

145

801

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

9.5

312

2140

G82.4

ICD-10 Finland

Spastic tetraplegia

100.4

9.4

XA402

NOMESCO Finland

ENMG

2.7

9.4

228

J01MA01

ATC

ofloxacin; systemic

1.7

9.3

178

1057

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

5.6

9.3

A07EC01

ATC

sulfasalazine; oral, rectal

1.8

9.3

162

932

R01AD09

ATC

mometasone; nasal

1.3

9.3

837

6911

D07AC01

ATC

betamethasone; topical

1.4

9.3

654

5195

M51.2

ICD-10 Finland

Other specified intervertebral disc displacement

6.9

9.3

A03FA02

ATC

cisapride; oral, rectal

1.8

9.3

151

853

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.0

9.3

109

546

TK800

NOMESCO Finland

Hemodialysis

2.9

9.2

183

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.9

9.2

139

768

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.0

9.2

168

GD1AD

NOMESCO Finland

Thorax CT examination

2.1

9.2

466

7240B

ICD-9 Finland

Other and unspecified disorders of back, Spinal stenosis, other than cervical[STENOSIS CANALIS SPINALIS LUMBOSACRALIS]

6.7

9.1

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

9.1

304

2092

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.7

9.1

179

1073

WX320

NOMESCO Finland

Spinalanesthesy

1.4

9.1

445

3317

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.8

9.1

156

896

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.5

9.0

265

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.5

9.0

265

Q07.0

ICD-10 Finland

Arnold-Chiari syndrome

36.8

9.0

NH1AD

NOMESCO Finland

Ankle and foot CT

2.9

9.0

180

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.6

9.0

258

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

2.9

9.0

187

C09AA05

ATC

ramipril; oral

1.4

9.0

466

3510

N06AX12

ATC

bupropion; oral

2.1

8.9

478

TAD08

NOMESCO Finland

Sympathetic block on sacral Level

18.7

8.9

A12AA04

ATC

calcium carbonate; oral

3.6

8.9

106

G04BD11

ATC

fesoterodine; oral

2.5

8.9

279

E0000UV

ATC

1.3

8.9

728

5918

FN1AD

NOMESCO Finland

CT of coronary arteries

3.5

8.9

117

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

8.9

315

2199

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.0

8.9

110

563

A10AE06

ATC

insulin degludec; parenteral

2.6

8.8

255

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

8.8

407

2998

R31

ICD-10 Finland

Unspecified haematuria

1.7

8.8

193

1194

S01.0

ICD-10 Finland

Open wound of scalp

1.8

8.8

145

822

ZZA00

NOMESCO Finland

Split skin graft

2.5

8.8

275

WW502

NOMESCO Finland

Autotransfusion

5.9

8.7

C10AC01

ATC

colestyramine; oral

2.7

8.7

224

KED33

NOMESCO Finland

Transurethral incision of prostate

3.7

8.7

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

2.2

8.7

421

UDC00

NOMESCO Finland

Ear microscopy

1.8

8.7

142

801

WX722

NOMESCO Finland

PEEP

2.1

8.7

102

509

N99

ICPC

Neurological disease other

4.2

8.7

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

2.9

8.7

173

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

8.7

514

3960

P03

ICPC

Feeling depressed

1.8

8.6

140

790

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

8.6

473

3594

I79.2*E11.5

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

7.7

8.6

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.9

8.6

174

H02AB09

ATC

hydrocortisone; systemic

2.8

8.6

187

XCK10

NOMESCO Finland

Photography of fundus of eye

1.6

8.6

199

1253

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.8

8.6

154

900

A02BC04

ATC

rabeprazole; oral

1.7

8.6

171

1031

R26.0

ICD-10 Finland

Ataxic gait

11.6

8.6

N06AX26

ATC

vortioxetine; oral

2.1

8.5

467

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

3.7

8.5

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

3.1

8.5

143

XG410

NOMESCO Finland

Flow-volume spirometry

2.1

8.5

433

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.3

8.5

313

318

Kela drug reimbursment

Teriparatide

6.4

8.5

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.8

8.4

151

882

J04AB02

ATC

rifampicin; systemic

3.7

8.4

G04BD07

ATC

tolterodine; oral

2.1

8.4

463

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

3.0

8.4

150

N03A

ATC

ANTIEPILEPTICS

12.8

8.4

R27.0

ICD-10 Finland

Ataxia, unspecified

7.9

8.4

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

+∞

8.3

ABC23

NOMESCO Finland

Open discectomy of thoracic spine

+∞

8.3

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

3.6

8.3

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

8.3

224

1465

M65.3

ICD-10 Finland

Trigger finger

2.1

8.3

431

M02AA10

ATC

ketoprofen; topical

1.5

8.3

314

2219

K30

ICD-10 Finland

Functional dyspepsia

1.7

8.2

184

1143

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.8

8.2

144

835

M01AB08

ATC

etodolac; oral

1.7

8.2

154

912

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

8.2

1351

12066

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

8.2

366

2675

R4110

SPAT

2.5

8.2

259

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

6.5

8.2

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.5

8.2

249

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

2.7

8.2

206

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.6

8.1

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

8.1

210

1359

A11CC03

ATC

alfacalcidol; systemic

2.9

8.1

164

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.3

8.1

785

6520

L09

ICPC

Arm symptom/complaint

2.1

8.1

409

NA7DM

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with 3 Tesla magnet

33.5

8.1

ZZH30

NOMESCO Finland

Bone allograft

33.5

8.1

J01MA06

ATC

norfloxacin; oral

1.5

8.1

245

1650

K05.31

ICD-10 Finland

Periodontitis pronounced

1.6

8.1

195

1239

Z43.5

ICD-10 Finland

Attention to cystostomy

6.8

8.1

C08CA02

ATC

felodipine; oral

1.7

8.0

179

1112

NAW10

NOMESCO Finland

Reoperation for superficial infection in in surgery of spine or neck

22.1

8.0

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.9

8.0

166

SPAT1151

SPAT

Treatment of major wounds

3.4

8.0

106

XQ800

NOMESCO Finland

Prick test

1.8

8.0

136

782

R06.4

ICD-10 Finland

Hyperventilation

3.3

8.0

117

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

8.0

186

1171

E87.6

ICD-10 Finland

Hypokalaemia

2.4

7.9

278

CKC15

NOMESCO Finland

Panretinal photocoagulation

4.9

7.9

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.5

7.9

252

R03AK11

ATC

formoterol and fluticasone; inhalant

2.6

7.8

209

C08CA13

ATC

lercanidipine; oral

1.5

7.8

248

1686

U28

ICPC

Limited function/disability (U)

4.3

7.8

N05BA12

ATC

alprazolam; oral

1.6

7.8

194

1241

H03AA01

ATC

levothyroxine sodium; systemic

1.4

7.8

411

3095

PD5AD

NOMESCO Finland

CT of aorta

3.2

7.8

119

R41.0

ICD-10 Finland

Disorientation, unspecified

2.6

7.8

200

XF402

NOMESCO Finland

ECG with work load test

1.6

7.8

218

1440

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

3.2

7.8

125

M01AX01

ATC

nabumetone; oral

2.0

7.8

457

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

3.9

7.7

SPAT1240

SPAT

Therapeutic discussion

1.7

7.7

171

1061

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.6

7.7

210

1376

S70.0

ICD-10 Finland

Contusion of hip

2.3

7.7

287

7221A

ICD-9 Finland

Intervertebral disk disorders, Displacement of thoracic or lumbar intervertebral disk without myelopathy

5.0

7.7

NA2BM

NOMESCO Finland

Thoracal spine MRI examination with 3 Tesla magnet

45.1

7.7

M14.6

ICD-10 Finland

Neuropathic arthropathy

15.1

7.7

S82.6

ICD-10 Finland

Fracture of lateral malleolus

1.9

7.7

117

646

A02BB01

ATC

misoprostol; oral

5.3

7.7

A10BB01

ATC

glibenclamide; oral

2.2

7.7

363

ZXF05

NOMESCO Finland

Interruption of procedure for other patient related reason

5.6

7.7

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.0

7.7

517

A99

ICPC

Disease/condition unspecnature/site

1.7

7.6

142

840

M10.9

ICD-10 Finland

Gout, unspecified

1.8

7.6

124

702

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

2.2

7.6

323

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

7.6

345

2529

N06AB06

ATC

sertraline; oral

1.6

7.6

187

1194

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

6.7

7.6

B01AF01

ATC

rivaroxaban; oral

1.5

7.6

225

1508

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

4.9

7.6

N02AJ13

ATC

tramadol and paracetamol; systemic

2.8

7.6

161

T91.8

ICD-10 Finland

Sequelae of other specified injuries of neck and trunk

11.9

7.6

NAG66

NOMESCO Finland

Posterior interbody fusion of lumbar spine, 2 vertebrae

4.5

7.6

NA7BT

NOMESCO Finland

Injection to spinal facet joint with radiological guidance

6.2

7.5

M14.6*E11.6

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic neuropathic

10.1

7.5

M76.0

ICD-10 Finland

Gluteal tendinitis

3.1

7.5

128

WX212

NOMESCO Finland

Femoral plexus blockade

3.0

7.5

134

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.6

7.5

206

1354

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

7.1

7.5

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

7.1

7.5

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.8

7.5

126

720

A07AA02

ATC

nystatin; oral

1.8

7.5

121

686

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.7

7.5

137

808

A10BK03

ATC

empagliflozin; oral

1.8

7.5

133

774

R25.2

ICD-10 Finland

Cramp and spasm

2.7

7.4

187

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.5

7.4

306

2201

D33.43

ICD-10 Finland

Spinal cord

80.3

7.4

NA7CM

NOMESCO Finland

Spine and spinal cord extensive MRI examination with 3 Tesla magnet

80.3

7.4

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

7.4

220

1473

M89.0

ICD-10 Finland

Algoneurodystrophy

5.0

7.4

EBA00

NOMESCO Finland

Extraction of tooth

1.3

7.4

603

4869

SPAT1279

SPAT

Preparation of immediate hospitalisation

4.2

7.4

M99.5

ICD-10 Finland

Intervertebral disc stenosis of neural canal

13.4

7.4

G57.3

ICD-10 Finland

Lesion of lateral popliteal nerve

3.5

7.4

NB1AD

NOMESCO Finland

Shoulder CT examination

3.1

7.3

125

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.5

7.3

228

1546

F45.8

ICD-10 Finland

Other somatoform disorders

1.9

7.3

108

592

F32.1

ICD-10 Finland

Moderate depressive episode

2.1

7.3

411

G95.1

ICD-10 Finland

Vascular myelopathies

+∞

7.3

G992, C795

ICD-10 Finland

+∞

7.3

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.3

7.3

296

N06

ICPC

Sensation disturbance other

4.2

7.3

T91.1

ICD-10 Finland

Sequelae of fracture of spine

9.4

7.3

S12.2

ICD-10 Finland

Fracture of other specified cervical vertebra

4.0

7.3

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.8

7.3

117

660

N06AB03

ATC

fluoxetine; oral

1.5

7.3

233

1590

M01AH03

ATC

valdecoxib; oral

1.7

7.3

133

781

C01CA24

ATC

epinephrine; parenteral

1.9

7.2

104

566

NH2AA

NOMESCO Finland

Heel X-ray examination

5.2

7.2

M96.0

ICD-10 Finland

Pseudarthrosis after fusion or arthrodesis

6.2

7.2

H05AA02

ATC

teriparatide; parenteral

5.8

7.2

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.0

7.2

485

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

7.2

444

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.2

7.2

312

UJD02

NOMESCO Finland

Gastroscopy

2.0

7.2

472

H02.4

ICD-10 Finland

Ptosis of eyelid

2.4

7.2

241

3540A

ICD-9 Finland

Mononeuritis of upper limb and mononeuritis multiplex, Carpal tunnel syndrome

3.7

7.2

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.8

7.2

111

621

B01AX06

ATC

[U] rivaroxaban; oral

2.6

7.1

186

B01AC07

ATC

dipyridamole; systemic

2.3

7.1

281

RS221

NOMESCO Finland

3.3

7.1

100

G62.8

ICD-10 Finland

Other specified polyneuropathies

4.4

7.1

A10BJ02

ATC

liraglutide; parenteral

2.5

7.1

205

L60.0

ICD-10 Finland

Ingrowing nail

2.1

7.1

374

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.8

7.1

114

644

QDA10

NOMESCO Finland

Incision of skin of lower limb

5.0

7.1

KCV04

NOMESCO Finland

Distension of bladder with fluid

4.2

7.1

N06AX03

ATC

mianserin; oral

2.0

7.1

481

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.3

7.1

255

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

1.9

7.1

510

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

7.1

574

4629

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.6

7.0

191

ABC99

NOMESCO Finland

Other decompressive operation on spinal cord or nerve root

8.8

7.0

A10BB12

ATC

glimepiride; oral

1.7

7.0

128

753

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

7.0

180

1163

C09AA02

ATC

enalapril; systemic

1.4

7.0

376

2836

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

4.3

7.0

J02AC02

ATC

itraconazole; systemic

1.4

7.0

327

2408

M75.8

ICD-10 Finland

Other shoulder lesions

2.3

7.0

288

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.9

7.0

138

H36.00

ICD-10 Finland

Diabetic background retinopathy

3.3

7.0

102

N05AA02

ATC

levomepromazine; systemic

2.0

6.9

408

M48

ICD-10 Finland

Other spondylopathies

6.3

6.9

NGQ20

NOMESCO Finland

Amputation of lower leg

6.3

6.9

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

3.4

6.9

ZSN00

NOMESCO Finland

Procedure related to previous procedure classified in chapter N

5.5

6.9

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

6.9

125

735

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

6.9

467

3663

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

6.9

408

3129

R00.2

ICD-10 Finland

Palpitations

1.8

6.9

121

702

H3602, E103

ICD-10 Finland

13.8

6.9

I79.2*E10.5

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

13.8

6.9

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.7

6.9

130

775

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

6.9

425

3287

N03AG01

ATC

valproic acid; systemic, rectal

1.9

6.9

511

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

2.0

6.9

389

S92.3

ICD-10 Finland

Fracture of metatarsal bone

2.2

6.8

285

E000001

ATC

1.4

6.8

362

2728

A29

ICPC

General symptom/complaint other

1.6

6.8

193

1278

N32.0

ICD-10 Finland

Bladder-neck obstruction

4.4

6.8

NAG61

NOMESCO Finland

Posterior fusion of lumbar spine without fixation

8.3

6.8

R03BA02

ATC

budesonide; inhalant

1.4

6.8

303

2212

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.1

6.8

381

SPAT1050

SPAT

Extensive neurological examination

2.7

6.8

166

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.2

6.8

288

SPAT1058

SPAT

PEF monitoring instruction

1.6

6.8

149

928

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

40.2

6.8

XF404

NOMESCO Finland

Ambulatory ECG

1.6

6.8

166

1060

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.1

6.8

335

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.8

6.8

107

600

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

3.0

6.7

116

I95.1

ICD-10 Finland

Orthostatic hypotension

2.3

6.7

257

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.2

6.7

290

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.0

6.7

122

Z49.2

ICD-10 Finland

Other dialysis

4.7

6.7

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

2.3

6.7

261

Z56.5

ICD-10 Finland

Uncongenial work

22.6

6.7

T92.4

ICD-10 Finland

Sequelae of injury of nerve of upper limb

22.6

6.7

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

6.7

200

1344

R06.5

ICD-10 Finland

Mouth breathing

1.6

6.7

162

1033

AA1AA

NOMESCO Finland

Head X-ray examination

4.9

6.7

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

6.7

474

3744

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.6

6.7

173

1124

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.1

6.6

366

S91.3

ICD-10 Finland

Open wound of other parts of foot

2.5

6.6

187

7227A

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[KAULANIKAMAN VÄLILEVYTYRÄ JUURIOIREINEEN]

6.4

6.6

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.1

6.6

340

R03BA08

ATC

ciclesonide; inhalant

1.6

6.6

149

931

G63.2

ICD-10 Finland

Diabetic polyneuropathy

5.2

6.6

WX872

NOMESCO Finland

Intensive care

1.9

6.6

533

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.8

6.6

115

667

N31.0

ICD-10 Finland

Uninhibited neuropathic bladder, not elsewhere classified

5.9

6.6

SPAT1234

SPAT

Support of social functional capacity

2.0

6.6

436

7211A

ICD-9 Finland

Spondylosis and allied disorders, Cervical spondylosis with myelopathy

12.3

6.6

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.6

6.6

AEA24

NOMESCO Finland

Removal of spinal stimulation elecrode

8.7

6.5

SFA00

NOMESCO Finland

Small filling

1.5

6.5

226

1567

L89

ICPC

Osteoarthrosis of hip

2.1

6.5

312

SPAT1284

SPAT

Extensive health certificate

2.3

6.5

235

U13

ICPC

Bladder symptom/complaint other

2.3

6.5

258

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.2

6.5

288

XA800

NOMESCO Finland

Neuropsychological investigation

2.0

6.5

374

R26.2

ICD-10 Finland

Difficulty in walking, not elsewhere classified

3.4

6.5

S76

ICPC

Skin infection other

1.9

6.5

484

P01BA02

ATC

hydroxychloroquine; oral

1.6

6.5

151

952

H26.02

ICD-10 Finland

Presenil cataract

2.3

6.5

259

G43.9

ICD-10 Finland

Migraine, unspecified

2.0

6.5

413

D07AC13

ATC

mometasone; topical

1.3

6.5

532

4288

G44.8

ICD-10 Finland

Other specified headache syndromes

4.1

6.5

N45.9

ICD-10 Finland

Orchitis, epididymitis and epididymo-orchitis without abscess

2.5

6.5

183

A02BA04

ATC

nizatidine; systemic

1.6

6.5

143

890

A10BJ06

ATC

semaglutide; parenteral

2.2

6.5

302

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.0

6.5

364

M46.4

ICD-10 Finland

Discitis, unspecified

5.3

6.5

G93.0

ICD-10 Finland

Cerebral cysts

70.0

6.4

ABC33

NOMESCO Finland

Decompression of thoracic nerve roots

70.0

6.4

NA1DM

NOMESCO Finland

Cervical spine very extensive MRI examination with 3 Tesla magnet

70.0

6.4

H53.2

ICD-10 Finland

Diplopia

2.3

6.4

250

K08.3

ICD-10 Finland

Retained dental root

1.7

6.4

129

783

R03AK08

ATC

formoterol and beclometasone; inhalant

2.1

6.4

344

XX1VW

NOMESCO Finland

Written report from radiologist

4.7

6.4

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.3

6.4

496

3965

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.6

6.4

156

995

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.8

6.4

525

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.2

6.4

276

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

1.8

6.4

541

T90.5

ICD-10 Finland

Sequelae of intracranial injury

3.8

6.4

L05

ICPC

Flank/axilla symptom/complaint

1.8

6.4

100

560

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.0

6.3

110

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.7

6.3

154

NC1CG

NOMESCO Finland

Elbow and forearm extensive MRI examination with high intensity magnet

6.6

6.3

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

2.2

6.3

257

D07AD01

ATC

clobetasol; topical

1.4

6.3

275

1997

NBB20

NOMESCO Finland

Primary total prosthetic replacement of humero-scapular joint

3.5

6.3

7225B

ICD-9 Finland

Intervertebral disk disorders, Degeneration of thoracic or lumbar intervertebral disk[DEGEN DISCI INTERVERT THORAC SEU LUMBOSACR CUM INST]

11.0

6.3

M86.8

ICD-10 Finland

Other osteomyelitis

11.0

6.3

A09AA02

ATC

multienzymes (lipase, protease etc.)

2.5

6.3

181

XG466

NOMESCO Finland

Sleep oxymetry

2.0

6.3

352

7245A

ICD-9 Finland

Other and unspecified disorders of back, Backache, unspecified

3.6

6.3

G06.1

ICD-10 Finland

Intraspinal abscess and granuloma

18.1

6.3

WX120

NOMESCO Finland

Intravenous local anesthesy of arm

2.9

6.3

126

G72.8

ICD-10 Finland

Other specified myopathies

2.9

6.3

117

G992, M513

ICD-10 Finland

+∞

6.3

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

+∞

6.3

M471G

ICD-10 Finland

+∞

6.3

G992, D434

ICD-10 Finland

+∞

6.3

ABE50

NOMESCO Finland

Occipitocervical decompression

+∞

6.3

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

6.2

338

2551

J20

ICD-10 Finland

Acute bronchitis

1.6

6.2

170

1117

M01AC01

ATC

piroxicam; systemic, rectal

1.4

6.2

266

1923

M13.9

ICD-10 Finland

Arthritis, unspecified

1.7

6.2

127

772

D33.4

ICD-10 Finland

Benign neoplasm: Spinal cord

26.7

6.2

WX202

NOMESCO Finland

Supraclavicular plexus blockade

3.0

6.2

106

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.5

6.2

189

1274

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

2.1

6.2

295

WX720

NOMESCO Finland

Own respiration

2.0

6.2

384

J34.2

ICD-10 Finland

Deviated nasal septum

1.8

6.2

561

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.2

6.2

274

M75

ICD-10 Finland

Shoulder lesions

1.9

6.2

426

L04AA01

ATC

[U] ciclosporin; systemic

3.1

6.2

101

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.1

6.2

296

TQW40

SPAT

2.2

6.2

287

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.6

6.2

159

N06AX17

ATC

milnacipran; oral

3.3

6.1

72870

ICD-8 Finland

Vertebrogenic pain syndrome, Lumbalgia

3.3

6.1

L10

ICPC

Elbow symptom/complaint

1.9

6.1

444

D07AB08

ATC

desonide; topical

1.5

6.1

185

1245

M05BA07

ATC

risedronic acid; oral

2.2

6.1

267

N06AA12

ATC

doxepin; systemic

1.8

6.1

102

587

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

6.1

139

874

C10AX09

ATC

ezetimibe; oral

1.5

6.1

202

1388

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

2.7

6.1

143

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.1

6.1

316

P20

ICPC

Memory disturbance

1.5

6.1

189

1284

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.9

6.1

436

WX308

NOMESCO Finland

Sacral anesthesy

8.6

6.1

R03DA04

ATC

theophylline; systemic, rectal

1.9

6.0

482

M01AB16

ATC

aceclofenac; oral

2.1

6.0

331

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

3.2

6.0

R5110

SPAT

2.3

6.0

230

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3032080) INR in Blood by Coagulation assay

1436

8432

2.66

122.15

8.2

9.4

1.2

1.3

inr

4.27

370

2434

(3044640) Blood type and Crossmatch panel - Blood

1185

6502

2.57

113.56

3.1

2.5

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1110

5968

2.55

110.19

2.6

2.1

229.3

240.2

u/l

0.13

1049

5581

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1528

9639

2.52

105.73

5.3

4.0

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1765

12055

2.60

100.55

6.8

4.7

6.9

6.8

mmol/l

2.33

1705

11320

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1553

10210

2.39

92.82

8.8

6.9

1.2

mmol/l

0.93

1267

8618

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1421

9296

2.23

81.60

7.9

6.1

1.2

mmol/l

0.74

1271

8402

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

905

5002

2.27

77.97

3.1

2.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1232

7845

2.13

72.85

4.7

3.5

121.5

52.0

ng/l

0.59

942

5468

(3023368) Bacteria identified in Blood by Culture

953

5652

2.11

66.31

6.0

4.4

—

(3026008) Bacteria identified in Urine by Culture

965

5813

2.08

63.83

4.7

3.0

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1942

15188

2.27

61.81

5.7

4.0

14.4

12.3

mm/h

6.48

1803

14016

(3037467) Urinalysis macro (dipstick) panel - Urine

1825

13956

2.15

61.06

6.5

4.2

—

(3013512) EKG study

1002

6248

2.01

59.11

5.1

3.8

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1035

6529

2.00

59.06

3.4

2.6

52.3

58.7

u/l

3.02

966

6009

(3024561) Albumin [Mass/volume] in Serum or Plasma

1307

9004

1.95

57.00

5.8

4.9

34.7

35.5

g/l

4.87

1207

8374

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1241

8422

1.94

56.38

2.3

2.0

95.1

94.9

pmol/l

0.05

673

4398

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2002

16181

2.21

53.54

9.5

7.6

80.9

78.8

u/l

0.65

1892

15249

(3031040) Bacteria [#/volume] in Urine by Automated count

1723

13193

1.99

53.27

6.7

4.3

381.8

1742.7

e6/l

1.45

184

(3042936) Bacteria identified in Isolate by Culture

567

2966

2.18

52.67

3.0

2.1

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1493

10946

1.91

51.92

6.4

10.3

11.6

umol/l

2.00

1409

10404

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

954

6051

1.93

51.83

3.1

3.0

1157.9

1376.1

ng/l

1.18

804

5151

(42870588) Differential panel, method unspecified - Blood

1065

7007

1.91

51.76

7.2

5.9

—

(3019309) Folate [Moles/volume] in Red Blood Cells

666

3742

2.06

51.09

2.0

1.7

1115.9

1181.4

nmol/l

0.99

503

2804

(3012095) Magnesium [Moles/volume] in Serum or Plasma

605

3372

2.05

46.89

3.5

3.4

0.8

mmol/l

0.30

557

3168

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

594

3319

2.04

45.55

2.1

1.8

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

732

4415

1.93

44.93

2.0

1.7

1.1

1.2

mg/l

0.83

549

3412

(3019225) pH of Specimen

425

2123

2.21

43.54

5.0

4.3

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1174

8277

1.79

43.19

2.7

2.2

77.4

77.9

nmol/l

0.24

1062

7414

(3021960) Folate [Moles/volume] in Serum or Plasma

758

4717

1.87

41.72

1.7

1.5

20.0

20.7

nmol/l

0.60

630

4014

(3003458) Phosphate [Moles/volume] in Serum or Plasma

503

2725

2.06

41.56

8.3

6.0

1.1

1.0

mmol/l

1.23

478

2535

(3003396) Base excess in Arterial blood by calculation

454

2375

2.11

41.15

6.8

7.6

1.1

mmol/l

0.17

371

1867

(3007853) Bacteria identified in Skin by Aerobe culture

452

2369

2.11

40.73

2.6

1.7

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

370

1792

2.25

40.70

2.3

2.1

337.1

373.7

nmol/l

3.34

333

1639

(3026782) Osmolality of Urine

670

4035

1.90

40.65

3.6

2.7

535.9

553.2

mosm/kgh2o

1.26

602

3416

(3019069) Monocytes/100 leukocytes in Blood

1305

9613

1.75

40.18

8.2

6.3

8.5

8.7

1.39

1229

8990

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

450

2376

2.09

39.68

6.9

7.6

5.2

5.1

kpa

1.32

431

2269

(3027801) Oxygen [Partial pressure] in Arterial blood

450

2376

2.09

39.68

6.8

7.6

13.4

12.2

kpa

3.65

430

2270

(3006504) Eosinophils/100 leukocytes in Blood

1298

9569

1.74

39.65

7.7

6.0

2.9

0.50

1221

8906

(3002030) Lymphocytes/100 leukocytes in Blood

1328

9855

1.75

39.61

7.8

6.1

26.6

27.6

2.71

1241

9160

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

789

5057

1.82

38.98

2.5

2.2

3.1

3.0

mg/l

0.29

671

4280

(3037522) Nuclear Ab [Titer] in Serum

484

2643

2.03

38.87

1.4

1.3

470.8

490.8

titre

0.08

568

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1873

15409

1.87

38.67

4.7

3.9

15.0

14.8

pmol/l

1.42

1699

13964

(3018010) Neutrophils/100 leukocytes in Blood

1305

9698

1.73

38.17

7.4

5.9

58.2

57.4

1.62

1222

9061

(3022096) Basophils/100 leukocytes in Blood

1263

9305

1.73

38.09

7.6

6.1

0.7

0.17

1185

8675

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

1057

7426

1.74

37.75

4.5

3.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

312

1453

2.31

37.52

1.8

1.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2304

20514

2.66

37.50

25.4

14.2

22.6

24.6

mg/l

2.47

2002

16201

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

699

4369

1.83

37.18

1.9

1.7

22518158.2

33416679.0

pmol/l

0.25

564

3618

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2155

18680

2.14

36.99

5.9

4.6

1.9

2.1

mu/l

1.04

1963

16982

(3009343) pH of Capillary blood

291

1325

2.35

36.83

4.6

3.6

7.4

0.11

173

(3006315) Basophils [#/volume] in Blood

1353

10219

1.71

36.72

7.2

5.8

0.0

e9/l

1.57

1222

8785

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1677

13442

1.76

36.61

4.3

3.1

60.7

52.8

u/l

1.43

1560

12448

(3019198) Lymphocytes [#/volume] in Blood

1375

10439

1.71

36.53

7.3

5.9

1.9

e9/l

0.24

1255

9162

(3001604) Monocytes [#/volume] in Blood

1346

10171

1.70

36.29

7.2

5.8

0.6

e9/l

2.36

1216

8745

(3013115) Eosinophils [#/volume] in Blood

1387

10573

1.70

36.13

7.4

6.0

0.2

e9/l

2.73

1256

9232

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

576

3414

1.89

36.10

1.3

36.8

36.3

iu/ml

0.03

176

1108

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

292

1343

2.33

36.09

4.6

3.6

5.3

5.2

kpa

1.42

274

1246

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

421

2241

2.06

36.04

5.0

3.4

—

(3016502) Oxygen saturation in Arterial blood

402

2122

2.07

35.14

7.0

8.0

96.0

95.5

0.85

388

2047

(3022948) Iron [Moles/volume] in Serum or Plasma

543

3201

1.89

34.41

3.2

2.5

11.5

13.3

umol/l

7.54

496

2965

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

277

1280

2.31

33.78

4.7

3.5

1.9

mmol/l

0.04

221

942

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

207

842

2.59

33.36

5.6

5.1

1.7

1.6

0.61

199

784

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1128

8267

1.67

33.01

3.7

2.8

140.7

144.5

ug/l

0.20

1025

7617

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

134

434

3.21

32.84

1.8

1.2

658.4

544.5

mg/l

0.76

127

404

(3020682) Albumin/Creatinine [Ratio] in Urine

960

6785

1.68

32.04

4.9

4.0

15.2

8.4

mg/mmol

2.68

659

4279

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

206

855

2.54

31.81

2.0

1.9

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

201

829

2.55

31.44

5.8

5.1

1.0

0.9

1.74

194

771

(3047181) Lactate [Moles/volume] in Blood

165

627

2.75

30.40

6.8

6.0

1.2

1.4

mmol/l

1.23

150

540

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

246

1129

2.31

30.38

8.7

10.5

—

(3033658) Prothrombin time (PT) actual/Normal

772

5215

1.70

30.17

4.8

3.9

91.3

89.6

1.06

745

5092

(3022313) Gas panel - Capillary blood

219

961

2.40

29.95

5.1

3.6

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

494

2946

1.84

29.71

2.7

2.1

29.3

29.9

1.47

472

2851

(3000850) Epithelial cells [#/volume] in Urine

663

4312

1.73

29.68

3.4

2.5

5.5

5.2

e6/l

0.18

597

3778

(3020630) Protein [Mass/volume] in Serum or Plasma

334

1746

2.05

29.67

2.7

65.6

66.7

g/l

1.44

308

1602

(3044290) Cell count panel - Cerebral spinal fluid

115

362

3.28

29.53

1.8

1.3

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

179

722

2.59

29.29

2.5

2.4

348.0

550.0

ug/l

0.86

163

684

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

473

2794

1.86

29.28

3.4

2.6

20.7

23.4

3.54

392

2397

(3018572) Chloride [Moles/volume] in Blood

131

448

3.03

29.26

7.0

6.9

105.3

mmol/l

0.03

124

396

(3039000) Anion gap in Blood

131

448

3.03

29.26

7.0

6.9

10.4

11.4

mmol/l

2.71

124

396

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

457

2671

1.87

29.26

5.0

4.6

32.3

32.1

0.09

342

1759

(3002173) Hemoglobin [Mass/volume] in Arterial blood

363

1967

1.99

29.14

7.6

8.4

121.5

122.4

g/l

0.33

352

1890

(3019550) Sodium [Moles/volume] in Serum or Plasma

2348

21500

2.63

28.68

28.0

16.3

139.5

139.7

mmol/l

3.80

2313

20951

(3019060) Gas panel - Arterial blood

277

1368

2.15

28.54

5.1

4.7

—

(3015736) pH of Urine

1032

7588

1.62

28.48

4.0

3.3

—

5.6

—

(3005719) IgG [Mass/volume] in Serum or Plasma

297

1508

2.10

28.47

3.1

2.8

9.8

10.7

g/l

3.16

263

1372

(3004789) Transferrin [Mass/volume] in Serum or Plasma

491

2977

1.81

27.78

3.3

2.5

2.3

g/l

0.30

448

2756

(3023103) Potassium [Moles/volume] in Serum or Plasma

2348

21564

2.57

27.32

28.2

16.5

4.0

mmol/l

3.07

2312

20989

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

183

772

2.48

27.24

1.9

1.8

—

(3009508) Creatinine [Moles/volume] in Urine

927

6695

1.61

27.21

3.9

3.2

7.3

7.6

mmol/l

1.50

760

5609

(3002582) Erythrocytes [#/volume] in Urine

877

6259

1.62

26.98

4.5

3.2

225.5

90.0

e6/l

0.49

754

4830

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

147

4.51

26.69

1.7

1.4

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1473

11893

1.58

26.59

9.9

9.2

4.3

4.1

e9/l

2.28

1337

10373

(3012516) Albumin [Mass/volume] in Urine

896

6450

1.61

26.48

4.1

3.3

659.8

283.0

mg/l

1.16

595

4067

(3009261) Glucose [Presence] in Urine by Test strip

1272

9940

1.57

26.38

4.8

3.6

0.0

estimate

1.34

254

1782

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

116

394

3.04

26.23

1.7

1.1

4.0

3.8

mmol/l

0.53

107

372

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

924

6717

1.60

26.12

3.3

3.2

33.4

35.4

u/l

0.42

872

6372

(3035350) Ketones [Presence] in Urine by Test strip

1257

9814

1.57

26.04

4.7

3.5

0.0

estimate

0.00

265

1817

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

196

872

2.35

25.92

1.9

2.0

3.0

1.8

ug/l

0.28

172

780

(3021601) Nitrite [Presence] in Urine by Test strip

1259

9840

1.57

25.91

6.4

4.8

0.0

estimate

0.50

270

1855

(3020779) Urea [Moles/volume] in Serum or Plasma

340

1873

1.94

25.84

10.1

7.7

10.0

10.1

mmol/l

0.12

328

1786

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

519

3270

1.74

25.51

1.3

1.2

24.1

12.5

u/ml

0.39

174

1258

(3030467) Casts [#/volume] in Urine by Automated count

809

5723

1.61

25.47

4.3

3.1

0.3

0.5

e6/l

1.86

686

4324

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

617

4088

1.68

25.15

1.3

1.2

1.4

1.6

u/ml

0.10

140

1066

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

110

372

3.05

25.06

1.7

1.2

16.6

26.2

e6/l

0.22

277

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

110

372

3.05

25.06

1.8

1.3

379.7

1619.9

e6/l

0.88

296

(3026493) Urate [Moles/volume] in Serum or Plasma

795

5625

1.61

24.89

3.2

2.7

3424.4

5012.5

umol/l

0.64

687

4897

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

131

4.59

24.79

1.6

1.2

2.2

mmol/l

0.03

123

(3008152) Bicarbonate [Moles/volume] in Arterial blood

254

1279

2.10

24.77

7.4

6.9

25.2

24.6

mmol/l

2.01

243

1188

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

185

823

2.35

24.46

5.7

3.8

25.1

24.8

mmol/l

0.58

177

766

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

402

2377

1.82

24.44

4.0

4.2

240.6

248.4

u/l

0.46

376

2250

(3004588) Protein electrophoresis panel - Serum or Plasma

277

1450

2.02

24.31

2.7

2.4

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

281

3.32

24.12

8.1

6.4

11.3

11.5

mg/l

0.12

264

(3015377) Calcium [Moles/volume] in Serum or Plasma

943

6988

1.56

24.00

3.0

3.5

2.3

2.4

mmol/l

1.15

792

6116

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

286

1534

1.98

23.39

5.4

3.9

96.6

91.0

ng/l

0.41

243

1339

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2152

19347

1.83

23.20

8.2

5.8

41.9

40.0

mmol/mol

12.16

2002

17851

(3018095) Leukocytes [#/volume] in Urine

963

7227

1.54

22.85

5.1

3.6

150.2

112.6

e6/l

0.28

786

5172

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

130

4.38

22.28

1.4

1.1

46.4

38.3

mg/l

0.71

108

(3000494) Fungus identified in Specimen by Culture

407

2492

1.76

21.81

1.7

1.4

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

127

4.32

21.14

1.3

1.0

401.2

276.4

mg/l

1.05

107

(40761511) CBC panel - Blood by Automated count

2310

21403

2.10

20.65

24.3

13.4

—

(3016018) Differential panel - Cerebral spinal fluid

184

3.66

20.48

1.9

1.3

—

(3018418) pH of Serum or Plasma

819

6046

1.53

20.38

5.9

4.1

7.4

0.23

193

1150

(3007164) IgA [Mass/volume] in Serum or Plasma

542

3649

1.62

20.14

1.6

1.5

2.4

2.5

g/l

0.37

326

2240

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

155

700

2.29

19.77

1.6

120.0

218.1

titre

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

122

4.25

19.55

1.2

1.0

—

(3048689) Calprotectin [Mass/mass] in Stool

366

2256

1.73

18.97

2.1

2.3

205.8

146.0

ug/g

1.30

279

1811

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

105

407

2.65

18.62

1.8

1.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

229

1234

1.94

18.36

1.9

1.6

—

(36304419) Bacteria [Presence] in Urine

753

5566

1.51

18.19

4.3

3.0

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

211

1111

1.98

18.09

7.2

10.2

24.5

24.4

mmol/l

0.14

195

1045

(40768797) Stomach Pathology biopsy report

449

2963

1.63

17.88

1.3

1.2

—

(4027681)

101

4.42

17.79

1.5

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

135

602

2.31

17.74

2.5

1.8

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

228

1247

1.91

17.47

4.5

3.1

126.0

128.9

g/l

1.02

218

1214

(3024869) Neuronal Ab [Presence] in Serum

7.42

17.39

1.1

—

(3017732) Neutrophils [#/volume] in Blood

253

1438

1.85

17.20

3.2

3.8

4.1

e9/l

1.41

192

1117

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

565

3975

1.55

17.02

4.6

3.6

290.6

667.7

ng/l

0.85

442

3174

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

193

3.32

16.98

2.8

2.5

—

(3002032) Base excess in Venous blood by calculation

313

1904

1.74

16.91

5.8

3.7

2.1

2.0

mmol/l

0.18

266

1531

(3027945) Reticulocytes/100 erythrocytes in Blood

370

2356

1.67

16.88

2.7

2.6

1.8

0.29

329

2097

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

966

7585

1.45

16.85

5.2

3.7

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

313

1912

1.73

16.65

5.9

3.7

5.9

kpa

0.06

304

1852

(3023520) Reticulocytes [#/volume] in Blood

295

1777

1.75

16.48

2.7

2.6

69.3

70.3

e9/l

0.20

238

1349

(3041096) Erythrocytes [Presence] in Urine by Automated

712

5302

1.48

16.23

4.9

3.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

118

3.95

16.11

1.6

2.0

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2344

22082

2.06

16.10

27.3

16.7

81.5

78.6

umol/l

2.28

2344

22075

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

482

3317

1.56

15.91

3.8

2.9

2.0

2.1

e6/l

0.12

309

1803

(40767503) Oxygen content in Capillary blood by calculation

108

459

2.41

15.84

2.7

2.6

15.7

16.1

0.44

240

(3000475) Leukocytes [#/volume] in Synovial fluid

115

505

2.34

15.67

1.7

13414.7

12832.1

e6/l

0.05

362

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

356

2288

1.65

15.60

2.0

1.7

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

121

547

2.27

15.42

2.5

3.3

24.9

25.0

mmol/l

0.13

112

483

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

356

2298

1.64

15.32

2.0

1.7

—

(3010421) pH of Blood

124

568

2.25

15.31

4.5

4.7

7.4

0.17

105

474

(1616796) Gas panel - Central venous blood

109

474

2.36

15.20

4.0

4.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

184

981

1.95

15.19

4.4

3.3

25.6

25.4

mmol/l

0.29

178

950

(40761536) Microorganisms panel - Urine sediment

282

1721

1.72

15.00

6.2

3.9

—

(3023183) Ammonium ion [Moles/volume] in Plasma

102

434

2.41

14.93

2.0

2.9

29.4

37.1

umol/l

3.61

370

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

502

3532

1.53

14.88

3.5

2.7

1.1

1.0

e6/l

0.22

328

2012

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

169

3.31

14.79

1.1

—

(3012501) Base excess in Blood by calculation

109

480

2.33

14.77

4.7

5.1

2.5

2.6

mmol/l

0.15

336

(3028026) IgM [Mass/volume] in Serum or Plasma

213

1210

1.83

14.46

2.6

1.8

1.7

1.4

g/l

0.32

188

1100

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

195

1081

1.87

14.31

2.6

2.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

4.52

14.24

1.6

1.5

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

123

582

2.17

14.05

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

274

1692

1.70

13.93

5.6

4.0

1.2

mmol/l

0.66

236

1464

(36660697) Celiac disease serology panel - Serum

242

1444

1.75

13.92

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

257

1560

1.72

13.91

4.8

2.9

4.8

4.6

kpa

1.02

245

1507

(3000570) Elastase.pancreatic [Mass/mass] in Stool

127

611

2.14

13.91

1.7

1.4

259.8

281.1

ug/g

0.52

363

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

113

3.76

13.80

1.2

1.4

—

(3045424) Erythrocytes [Presence] in Urine

358

2.48

13.71

1.4

1.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2334

22093

1.91

13.70

14.5

10.6

27.1

26.8

u/l

0.26

2250

21304

(3015171) Extractable nuclear Ab [Units/volume] in Serum

144

733

2.02

13.57

1.3

1.2

1.7

1.0

u/ml

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

115

3.70

13.46

1.2

1.4

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

312

2010

1.63

13.45

2.4

2.2

0.2

g/l

1.16

292

1882

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

207

1192

1.80

13.44

1.5

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2176

20253

1.59

13.05

5.6

4.6

6.2

6.0

mmol/l

10.42

1966

18431

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

120

581

2.12

12.94

1.4

—

(3008037) Lactate [Moles/volume] in Venous blood

100

450

2.27

12.92

3.9

3.1

1.6

1.5

mmol/l

0.49

433

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

352

2356

1.58

12.92

2.6

2.7

8.9

8.2

umol/l

0.11

293

2077

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

159

853

1.92

12.90

2.3

1.9

40.3

38.8

u/l

0.45

138

753

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

172

949

1.87

12.81

1.8

1.6

1.5

g/l

0.64

146

822

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

124

611

2.08

12.78

1.6

1.7

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

116

560

2.12

12.61

1.5

0.2

g/l

0.37

106

532

(3029937) Albumin [Presence] in Urine by Test strip

690

5310

1.41

12.61

5.3

3.9

0.0

estimate

0.04

257

1774

(3004616) Nuclear Ab [Presence] in Serum

249

2.70

12.43

1.5

1.2

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

381

2626

1.53

12.23

7.3

103.9

104.3

mmol/l

0.92

366

2567

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

252

2.66

12.15

2.0

2.3

29.1

20.4

mg/l

0.29

(3045414) Leukocytes [Presence] in Urine

165

915

1.86

12.10

1.7

1.9

—

(3000991) Gas panel - Venous blood

271

1733

1.63

11.99

9.7

8.8

—

(1761482) Bacteria [#/volume] in Urine by Culture

109

524

2.13

11.99

5.5

4.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

385

2676

1.52

11.86

1.8

1.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

117

583

2.06

11.72

1.5

1.2

g/l

0.01

110

554

(3014111) Lactate [Moles/volume] in Serum or Plasma

282

1836

1.60

11.59

7.3

1.4

mmol/l

0.04

270

1773

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

107

518

2.11

11.57

1.3

1.2

1.3

3.8

u/ml

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

108

525

2.11

11.55

1.3

1.2

1.8

6.6

u/ml

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

124

3.35

11.36

1.8

2.4

521.1

572.1

e6/l

0.19

111

(40760888) Immunoglobulin light chains.free panel - Serum

105

510

2.11

11.26

3.4

3.8

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

239

2.63

11.23

2.9

2.6

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

273

1780

1.60

11.14

2.4

2.3

8.2

7.5

ug/l

0.16

228

1581

(3037756) Immunofixation for Serum or Plasma

440

2.18

11.08

1.6

1.7

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

163

927

1.81

11.03

4.0

2.6

0.7

0.08

157

886

(3000330) Specific gravity of Urine by Test strip

177

1032

1.77

11.02

4.6

3.4

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2112

19714

1.47

10.55

20.6

13.4

79.6

79.8

ml/min/173m2

0.11

1862

16309

(3006653) Thiamine [Moles/volume] in Blood

101

3.50

10.44

1.3

126.8

142.8

nmol/l

1.03

101

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

121

3.26

10.41

1.8

2.4

0.2

e9/l

0.39

111

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

146

825

1.82

10.11

2.5

2.4

7.3

7.4

g/l

0.31

100

634

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

146

825

1.82

10.11

2.5

2.4

—

(3021901) Oxygen saturation in Capillary blood

397

2.18

10.10

2.5

2.9

—

(3002179) Metamyelocytes/100 leukocytes in Blood

250

1637

1.59

10.01

4.0

3.9

0.8

0.6

0.45

379

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

130

713

1.87

9.90

2.9

2.7

—

(3028626) Oxygen [Partial pressure] in Capillary blood

474

2.07

9.90

2.6

3.0

8.0

kpa

0.00

437

(3037121) Protein [Mass/volume] in Urine

132

728

1.86

9.88

3.5

3.4

0.6

0.3

g/l

1.45

313

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

145

825

1.80

9.82

2.6

2.4

3.7

3.8

g/l

0.32

600

(3017181) Myelocytes/100 leukocytes in Blood

268

1794

1.55

9.74

4.2

4.1

1.2

0.9

0.53

522

(3021440) Promyelocytes/100 leukocytes in Blood

258

1713

1.56

9.72

4.2

0.1

0.07

486

(3024731) MCV [Entitic volume]

2377

22891

1.85

9.41

35.1

20.9

91.5

91.2

1.57

2351

22545

(3035941) MCH [Entitic mass]

2377

22893

1.85

9.38

35.0

20.9

30.4

0.33

2352

22547

(3026361) Erythrocytes [#/volume] in Blood

2377

22895

1.85

9.34

35.2

21.0

4.4

4.5

e12/l

18.39

2337

22220

(3010813) Leukocytes [#/volume] in Blood

2377

22899

1.85

9.28

35.2

21.0

7.1

6.7

e9/l

9.25

2337

22225

(3007461) Platelets [#/volume] in Blood

2376

22887

1.84

9.27

35.2

21.0

254.2

248.3

e9/l

4.22

2342

22281

(3000963) Hemoglobin [Mass/volume] in Blood

2377

22901

1.84

9.25

35.4

21.1

132.9

136.1

g/l

19.54

2351

22556

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

488

2.01

9.17

1.5

1.6

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

468

2.03

9.13

2.5

2.2

124.6

129.8

g/l

1.14

338

(3005322) IgE [Units/volume] in Serum or Plasma

191

1202

1.64

9.00

1.4

1.3

278.2

204.6

u/ml

0.35

172

1108

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.21

8.91

1.1

1.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

119

658

1.85

8.86

3.3

3.6

3.4

2.8

ratio

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

332

2373

1.46

8.79

1.8

1.7

1.5

3.15

276

2085

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

119

3.05

8.70

1.3

1.6

5.2

8.5

u/l

1.34

101

(3011985) Renin [Units/volume] in Plasma

252

2.37

8.70

1.4

76.8

56.3

mu/l

0.47

225

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

133

769

1.77

8.57

2.4

9.1

10.4

g/l

4.71

107

664

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

3.63

8.56

1.3

1.1

358.2

626.1

ng/l

—

(3004809) Band form neutrophils/100 leukocytes in Blood

357

2.14

8.55

4.0

3.6

1.5

0.03

275

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

133

771

1.77

8.49

2.6

2.4

2.8

3.1

g/l

2.62

616

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

3.36

8.48

2.6

2.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

290

2033

1.48

8.46

1.8

1.6

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

120

676

1.81

8.43

3.5

3.6

43.9

65.9

mg/l

0.96

544

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

5.18

8.40

1.5

1.0

—

(3004451) EKG impression Narrative

111

3.09

8.40

1.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

120

677

1.81

8.39

3.5

3.6

26.6

81.3

mg/l

1.87

547

(3025159) Blasts/100 leukocytes in Blood

238

1605

1.53

8.36

4.3

4.2

0.0

0.5

1.04

406

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

101

3.20

8.36

1.2

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2181

20665

1.45

8.33

5.4

4.5

4.7

mmol/l

10.20

1989

19091

(3008757) Leukocyte morphology finding [Identifier] in Blood

227

2.41

8.26

5.4

4.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

182

1159

1.62

8.19

2.9

3.3

4.3

4.5

pmol/l

1.81

154

1025

(3022217) INR in Platelet poor plasma by Coagulation assay

362

2675

1.41

7.97

22.8

24.6

1.2

1.3

inr

1.80

364

(3017704) Immunofixation for Urine

131

2.85

7.96

1.3

1.7

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2164

20519

1.42

7.81

5.4

4.4

1.4

1.5

mmol/l

7.66

1965

18840

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2103

19847

1.38

7.78

4.8

4.0

1.4

1.3

mmol/l

5.53

1901

18098

(3011412) CD3 cells [#/volume] in Blood

185

2.51

7.75

2.0

2.2

1.2

1.1

e9/l

0.17

113

(3051593) INR in Capillary blood by Coagulation assay

3.55

7.69

20.0

18.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

3.15

7.68

1.3

1.0

1.1

u/l

0.67

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

3.36

7.66

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2210

21053

1.44

7.59

5.9

5.0

2.6

2.8

mmol/l

13.63

2006

19336

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

403

1.99

7.53

1.2

52.3

47.7

u/ml

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

5.20

7.45

5.3

4.4

—

(3044941) Cell count panel - Synovial fluid

339

2.06

7.30

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

3.11

7.28

1.1

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

3.11

7.28

1.1

1.5

—

(3038026) Centromere Ab [Units/volume] in Serum

173

2.51

7.26

1.3

1.1

—

45.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

3.32

7.24

1.1

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

247

1734

1.47

7.15

3.8

2.7

148.4

200.0

ng/l

1.82

235

1582

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

106

2.95

7.12

1.2

1.1

—

(3044927) Protein electrophoresis panel - Urine

224

2.30

7.12

1.2

—

(3025941) Bacteria identified in Stool by Culture

170

1103

1.58

7.10

1.3

—

(3023410) Appearance of Cerebral spinal fluid

181

2.46

7.10

2.1

1.4

—

(3019150) Specific gravity of Urine by Refractometry

534

4272

1.32

7.03

4.5

3.9

1.0

kg/l

0.42

108

609

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

4.86

6.93

1.3

1.5

83.4

130.4

ng/l

1.11

(3010144) Erythrocytes [#/volume] in Synovial fluid

202

2.35

6.90

1.4

26639.6

59567.9

e6/l

0.46

144

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

266

2.17

6.90

1.7

1.5

53.2

58.2

0.38

165

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

109

2.87

6.79

1.1

—

(3042733) HLA Ab [Presence] in Serum

3.51

6.71

6.0

5.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

211

2.30

6.71

3.8

3.5

62.1

56.1

0.94

132

(40768804) Tissue Pathology biopsy report

974

8442

1.25

6.70

2.2

2.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

225

2.25

6.62

3.3

6.3

6.9

7.4

mmol/l

0.69

192

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

145

2.58

6.61

1.5

1.4

—

(3021788) Differential panel - Synovial fluid

380

1.95

6.61

1.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

245

2.19

6.58

1.3

1.4

317.3

287.3

pmol/l

0.25

191

(4010399)

216

1503

1.48

6.54

1.4

—

(3036489) Thrombin time

115

692

1.69

6.50

2.7

1.9

21.1

21.8

0.66

102

611

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.02

6.50

1.7

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.02

6.50

1.7

1.9

—

(3004775) Volume in Urine collected for unspecified duration

177

2.40

6.46

2.5

2.2

595.7

645.6

0.28

113

(4015189)

3.52

6.43

4.4

2.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

117

711

1.68

6.38

2.6

2.4

0.6

1.3

g/l

1.40

624

(3009214) Lutropin [Units/volume] in Serum or Plasma

421

1.88

6.36

1.6

1.3

12.6

9.4

u/l

1.02

335

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

523

1.79

6.35

2.1

2.0

10.8

11.9

mg/l

0.46

482

(21494755) Public health laboratory ask at order entry panel

105

1710

0.60

6.30

1.2

1.4

—

(3003694) ABO and Rh group [Type] in Blood

665

5544

1.27

6.29

1.4

1.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

3.46

6.28

2.0

2.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

338

1.98

6.28

1.3

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.96

6.27

1.7

1.9

—

(3022145) Colonoscopy Study observation

316

2374

1.38

6.27

1.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

547

4453

1.29

6.25

4.9

4.5

—

(3014271) Vancomycin [Susceptibility]

104

2.81

6.16

3.5

2.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1328

11978

1.23

6.15

2.9

2.6

—

(3022621) pH of Urine by Test strip

186

1273

1.50

6.12

3.3

2.9

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

112

681

1.68

6.11

4.0

2.8

0.3

u/ml

0.21

385

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

552

1.75

6.10

4.0

3.1

1.7

1.6

mg/l

0.60

505

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

119

738

1.64

6.02

1.1

—

1.4

u/ml

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

4.54

5.98

8.9

12.2

4.5

5.7

mmol/l

1.16

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

548

1.74

5.98

2.6

2.3

183.4

112.3

ug/min

0.38

334

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

263

2.08

5.91

1.2

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

917

7978

1.24

5.89

4.7

4.9

2.2

2.8

ug/l

1.48

829

7158

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

160

2.40

5.88

1.3

1.1

—

4.7

—

(3006270) Folate [Moles/volume] in Blood

160

2.40

5.88

1.2

301.2

375.9

nmol/l

1.28

139

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.54

5.88

1.2

1.1

—

(3021589) Normoblasts [#/volume] in Blood

1035

9123

1.23

5.87

14.8

9.7

0.0

e9/l

0.43

911

7438

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

426

1.83

5.84

5.9

5.1

523.5

694.6

iu/ml

0.19

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

231

2.14

5.83

1.6

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

113

2.68

5.83

1.6

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

113

2.68

5.83

1.6

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

113

2.68

5.83

1.6

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

113

2.68

5.83

1.6

1.8

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

463

1.80

5.82

4.6

1.9

0.9

0.8

nmol/l

0.27

379

(3035637) Corticotropin [Mass/volume] in Plasma

225

2.16

5.80

1.4

1.5

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.09

5.77

2.4

1.6

89.5

101.9

umol/l

0.13

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

443

1.81

5.74

1.3

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

364

1.89

5.72

1.3

1.2

—

(3024928) Oxygen saturation in Venous blood

444

1.80

5.70

5.1

2.7

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

149

989

1.54

5.68

7.0

4.0

24.3

24.1

mmol/l

0.28

131

883

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

175

1202

1.49

5.68

1.2

118.8

158.9

iu/ml

0.77

446

(3024980) IgG subclass 4 [Mass/volume] in Serum

317

1.95

5.60

1.3

1.7

0.4

0.9

g/l

3.91

248

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

300

2277

1.36

5.58

1.8

1.5

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

209

2.17

5.57

1.4

1.2

57.9

57.4

u/l

0.02

147

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

340

2637

1.34

5.48

7.1

6.6

—

(3020891) Body temperature

126

812

1.58

5.48

5.2

4.7

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

517

1.73

5.47

1.3

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

386

1.84

5.39

1.6

1.7

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

142

2.41

5.38

1.7

2.2

816.4

610.3

e6/l

0.70

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

671

5688

1.25

5.38

1.8

1.6

1.5

1.4

mmol/l

1.50

555

4740

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

3.56

5.32

1.6

1.5

0.6

0.4

ug/l

0.61

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

5.02

5.26

2.1

2.9

0.8

0.5

u/field

0.35

(3003181) Sodium [Moles/volume] in Urine

347

1.87

5.21

1.4

59.7

60.2

mmol/l

0.03

276

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

243

2.04

5.15

1.2

1.3

—

nmol/l

—

(3052851) Hemolysis interference index of Serum or Plasma

611

1.65

5.15

4.1

3.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

217

2.09

5.10

1.6

1.7

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.77

5.09

1.2

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

104

2.61

5.06

1.8

1.6

2.0

2.1

u/field

0.03

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

134

2.41

5.05

1.9

1.6

10.1

6.5

u/l

0.52

(4146454)

252

2.00

5.04

2.6

2.7

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

507

1.70

5.04

1.6

1.7

—

(3049717) Cytology report of Urine Cyto stain

128

845

1.54

5.03

2.4

2.6

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

103

647

1.62

5.01

2.3

2.2

38.4

37.7

g/l

0.76

563

(40761535) Cells panel - Urine sediment

232

1720

1.38

5.00

3.8

3.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

135

2.39

4.98

1.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

524

1.68

4.98

1.6

—

(3008898) HLA-B27 [Presence]

100

627

1.62

4.90

1.1

—

(3042631) Mycobacterium sp identified in Specimen

305

1.89

4.85

2.3

2.8

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

150

2.28

4.80

1.3

1.4

1.3

promille

0.01

116

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.75

4.77

1.2

1.4

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

3.12

4.63

1.8

1.5

14.0

15.9

pmol/l

0.44

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

591

1.61

4.58

3.0

2.0

96.2

90.1

1.73

557

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

462

3817

1.26

4.57

2.9

3.1

2.4

2.5

mmol/l

0.14

401

3363

(3044889) 12 lead EKG panel

1596

14893

1.20

4.47

4.6

3.8

—

(4062490)

188

2.09

4.46

1.4

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

118

1727

0.67

4.44

1.6

1.8

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

4.01

4.43

1.2

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

265

1.90

4.41

1.3

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

164

1173

1.43

4.37

1.9

1.7

—

(3009542) Hematocrit [Volume Fraction] of Blood

1960

18672

1.23

4.37

24.1

15.2

38.5

39.9

5.69

1168

13226

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

4.25

4.35

1.0

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

339

1.79

4.34

1.3

1.2

289.7

268.4

u/ml

0.20

202

(3021879) Hepatitis B virus core Ab [Presence] in Serum

181

1320

1.40

4.32

1.5

1.4

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

561

1.61

4.31

3.8

2.4

3.7

3.6

g/l

0.22

532

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

340

1.78

4.30

1.1

19.9

90.3

iu/ml

1.17

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

261

1.90

4.27

1.3

1.4

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.88

4.25

1.2

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

186

2.06

4.20

1.4

1.5

0.4

g/l

0.36

132

(3027135) IgG subclass 1 [Mass/volume] in Serum

186

2.06

4.20

1.4

1.5

5.5

6.8

g/l

1.54

133

(3028192) IgG subclass 2 [Mass/volume] in Serum

186

2.06

4.20

1.4

1.5

2.5

2.9

g/l

1.02

133

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

419

1.69

4.15

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

419

1.69

4.15

1.4

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

187

2.05

4.14

1.2

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

264

1.87

4.13

1.3

1.4

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

128

2.28

4.13

1.2

1.4

—

545.5

—

(40758558) Short blood count panel - Blood

611

5255

1.22

4.12

7.4

6.8

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

346

1.75

4.07

1.4

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

626

1.55

4.05

2.4

2.3

0.0

g/l

1.10

577

(3025468) Yersinia sp identified in Specimen by Organism specific culture

259

1.87

4.04

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

259

1.87

4.04

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

189

2.03

4.03

1.8

2.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

252

1959

1.32

4.01

3.5

2.4

32.8

64.1

u/l

0.70

216

1690

(3003327) Ova and parasites identified in Stool by Light microscopy

612

1.56

4.00

1.6

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.94

3.97

1.0

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

2.83

3.95

2.7

3.0

26.6

28.8

umol/l

0.39

(3005988) Vibrio sp identified in Specimen by Organism specific culture

261

1.86

3.95

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

108

728

1.51

3.93

1.5

1.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

366

1.71

3.89

3.8

3.4

—

(40768443) Skin Pathology biopsy report

130

912

1.45

3.88

1.3

1.2

—

(3048879) Bone marrow aspiration report

2.98

3.85

1.6

2.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

300

1.78

3.85

2.4

1.9

73.4

1845.1

u/l

—

107

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

215

1.92

3.77

1.2

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

517

1.59

3.77

1.5

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

353

2889

1.26

3.77

1.4

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

12.02

3.76

1.3

1.2

564.0

569.7

nmol/l

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

175

1304

1.37

3.71

2.0

1.8

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

505

1.58

3.66

1.2

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

5.64

3.65

1.7

1.0

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

3.26

3.62

1.0

1.2

0.6

0.7

umol/24h

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1136

0.64

3.55

1.4

1.5

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

541

1.55

3.55

3.9

2.3

209.3

190.2

1.04

511

(3032057) Clostridioides difficile [Presence] in Stool

3.06

3.53

1.9

2.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.82

3.52

1.3

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

385

1.65

3.51

1.7

1.4

—

(3000060) B lymphocytes [#/volume] in Blood

3.18

3.49

1.5

2.4

90.0

150.0

e6/l

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

514

1.55

3.42

1.4

1.3

—

(3008295) Osmolality of Serum or Plasma

209

1.88

3.40

1.2

1.3

283.5

277.0

mosm/kgh2o

0.87

157

(3028433) Virus identified in Specimen by Culture

2.58

3.38

1.1

1.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

343

1.68

3.38

1.7

1.4

124.1

123.7

u/ml

0.01

(3026389) Candida sp identified in Specimen by Organism specific culture

246

1.80

3.36

1.5

1.3

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

7.01

3.36

1.3

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

279

2252

1.27

3.35

3.0

4.3

113.6

23.8

ug/l

0.44

238

1849

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

5.73

3.34

1.0

—

22.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

141

2.07

3.32

1.1

1.2

—

(40768446) Kidney Pathology biopsy report

2.42

3.30

1.9

1.6

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.48

3.29

1.1

1.0

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

594

1.50

3.23

2.4

2.3

0.0

g/l

0.00

546

(3025315) Body weight

4.75

3.23

6.3

4.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

3.58

3.19

1.7

1.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

621

1.48

3.18

1.6

1.3

11.1

iu/ml

0.49

122

(3011397) Hemoglobin [Presence] in Urine by Test strip

532

4620

1.19

3.16

4.2

3.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

117

2.15

3.16

1.3

1.4

1.1

1.2

nmol/l

0.20

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

304

1.69

3.15

1.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

297

1.70

3.13

1.5

—

(3020491) Glucose [Moles/volume] in Blood

138

2.04

3.11

1.7

2.0

6.8

7.0

mmol/l

0.11

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.59

3.04

1.3

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.59

3.04

1.3

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

587

1.48

3.02

2.4

2.3

0.0

g/l

0.00

545

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.36

2.98

2.3

2.8

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

10.02

2.98

1.2

1.8

—

(3052592) Norovirus Ag [Presence] in Stool

3.15

2.93

1.5

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

2.22

2.89

1.8

2.6

1096.0

1280.6

u/ml

0.17

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.60

2.87

1.3

1.1

—

(3016750) Collection duration of Urine

137

1.98

2.80

2.5

2.1

527.3

491.1

min

0.73

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.92

2.77

1.8

2.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.92

2.77

1.2

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.92

2.77

1.8

2.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

460

1.51

2.74

2.1

1.7

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

5.01

2.73

1.0

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

182

1.82

2.69

1.5

1.7

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.76

2.67

1.0

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

133

1.96

2.65

2.0

2.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

2.40

2.63

1.4

1.2

42.8

37.9

g/l

—

(3024932) HLA-DR beta [Type]

2.40

2.63

1.1

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

416

1.53

2.62

4.4

3.7

60.7

57.9

1.15

416

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

141

1.92

2.60

2.1

2.0

14.7

13.4

0.28

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

127

1.98

2.60

1.0

845.5

716.5

ng/l

0.70

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.61

2.57

1.3

1.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.19

2.57

1.3

1.2

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

128

1.96

2.55

1.1

1.0

371.5

317.9

ng/l

0.19

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

128

1.96

2.55

1.0

37.4

44.5

ng/l

0.44

(3011288) Drugs identified in Urine by Screen method

292

1.62

2.54

1.6

2.6

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

208

1.74

2.54

1.9

1.6

—

(3001019) Free T4 and TSH panel - Serum or Plasma

925

0.67

2.52

1.8

1.7

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

179

1.80

2.51

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

381

1.53

2.49

1.5

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

202

1630

1.26

2.49

2.4

2.2

12.3

13.1

nmol/l

0.77

177

1437

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

202

1.74

2.48

1.2

1.5

28.8

32.8

0.24

124

(3024471) HLA-A [Type]

2.33

2.48

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.82

2.46

1.3

1.2

—

(3012898) Urea [Moles/volume] in Urine

3.82

2.46

1.1

1.2

236.8

147.3

mmol/l

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

2.39

2.46

1.9

2.7

1.4

1.2

ug/l

0.10

(3022689) Creatine [Moles/volume] in Urine

2.46

2.45

1.4

1.5

—

(3037556) Urate [Mass/volume] in Serum or Plasma

2.25

2.44

1.1

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

204

1.73

2.41

4.3

3.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

190

1.75

2.37

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

190

1.75

2.37

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

190

1.75

2.37

1.6

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.64

2.36

1.3

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.51

2.36

1.0

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

133

1.89

2.31

1.8

2.7

36.6

38.5

—

(3002619) Bacteria identified in Specimen by Culture

2.86

2.30

1.8

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

168

1340

1.27

2.29

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.38

2.29

1.3

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

246

1.64

2.28

1.6

1.8

—

(21494890) Protein electrophoresis panel - 24 hour Urine

231

1.66

2.27

1.7

1.9

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

590

1.40

2.26

1.3

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

120

1.93

2.25

1.5

1.2

17.2

21.6

u/l

0.37

103

(3039443) Prostate specific Ag panel - Serum or Plasma

505

0.59

2.23

1.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

164

1.78

2.23

2.0

2.2

3.4

1.9

u/field

0.48

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.20

2.21

1.2

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

336

1.53

2.20

1.5

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

2.41

2.19

1.3

1.1

314.5

258.5

pmol/l

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

312

1.55

2.19

1.5

1.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.51

2.18

1.7

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.63

2.18

2.9

2.7

—

(42529406) Shigella sp [Presence] in Stool by Culture

595

1.39

2.16

1.3

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

3.01

2.14

1.4

2.2

17.5

18.5

umol/l

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.01

2.14

1.2

1.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

189

1.70

2.13

1.3

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

315

1.53

2.11

1.4

1.5

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

145

1.80

2.10

1.2

1.3

0.2

0.9

u/ml

0.79

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.57

2.09

1.5

1.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

465

1.43

2.06

1.6

1.7

290.7

300.5

mu/l

0.07

428

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

103

1.95

2.05

1.1

1.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.33

2.04

1.2

1.4

92.9

87.6

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

343

1.50

2.02

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.08

2.01

1.0

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

587

1.37

2.00

1.4

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

148

1.76

1.98

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

148

1.76

1.98

1.2

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

648

1.36

1.98

1.7

1.4

24.4

32.2

iu/l

1.65

554

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

126

1.83

1.98

1.5

1.2

71.6

85.2

u/l

0.51

110

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.29

1.97

1.2

1.1

—

(40768800) Prostate Pathology biopsy report

524

0.62

1.97

1.1

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.99

1.95

1.2

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

296

0.50

1.95

1.4

1.5

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

4.55

1.94

17.4

11.8

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

180

1.67

1.92

1.3

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

150

1.74

1.90

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

150

1.74

1.90

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

150

1.74

1.90

1.2

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

308

1.50

1.88

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

350

1.47

1.85

1.7

1.8

—

(3014051) Protein [Presence] in Urine by Test strip

459

1.40

1.85

2.3

2.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

3.54

1.83

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

4.17

1.82

1.4

5.2

—

(4035726)

228

1932

1.20

1.82

1.4

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.27

1.80

1.1

—

(4024509)

207

1.60

1.80

1.6

1.5

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.05

1.80

1.0

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

3.05

1.80

1.3

2.1

—

(3029075) Extractable nuclear Ab panel - Serum

2.17

1.77

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.17

1.77

1.2

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

131

1.76

1.77

1.1

1.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

147

1.71

1.74

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

465

1.39

1.73

1.5

1.9

2.9

5.0

iu/l

2.40

158

(21494815) CD4 cells/100 lymphocytes in Specimen

163

1.66

1.71

2.0

42.6

45.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

250

1.53

1.71

1.2

1.0

3.6

2.6

u/ml

—

107

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

218

1.57

1.70

3.1

3.8

—

(3001186) Copper [Moles/volume] in Serum or Plasma

2.30

1.70

1.6

1.3

15.5

16.2

umol/l

0.17

(40759836) Histone Ab [Presence] in Serum by Immunoblot

148

1.70

1.2

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

133

1.74

1.70

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.19

1.67

1.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

3.16

1.66

1.0

1.3

8.2

16.2

u/l

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

188

1.60

1.66

2.5

2.4

—

(3023420) DNA double strand Ab [Units/volume] in Serum

204

1.58

1.65

1.2

1.4

—

28.5

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.80

1.65

1.1

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

487

1.36

1.64

1.6

1.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

189

1.59

1.63

1.2

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

344

1.43

1.62

1.1

1.4

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

3.58

1.61

1.2

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

584

1.33

1.61

2.2

1.7

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.15

1.61

1.2

1.1

99.7

88.9

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

426

4724

0.88

1.60

2.8

3.1

0.7

0.8

ug/l

1.78

288

3159

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.01

1.59

1.0

1383.9

1610.0

miu/ml

0.28

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

483

1.36

1.56

2.5

3.3

886.3

901.3

u/ml

0.01

454

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.89

1.55

1.1

1.4

—

(3000012) Reticulocyte production index

115

1.75

1.52

1.3

1.6

—

(3006462) Nitrate [Presence] in Urine

1.90

1.49

4.5

3.6

—

(4034850)

671

1.29

1.49

12.6

9.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.07

1.49

1.6

1.3

10.1

8.8

ug/l

0.38

(3007566) Smooth muscle Ab [Titer] in Serum

566

1.32

1.48

1.1

1.2

48.0

98.6

titre

—

(3025577) Chromium [Mass/volume] in Blood

139

1.66

1.48

2.1

2.0

1.5

2.1

ug/l

0.97

120

(4211845)

1.84

1.45

4.3

3.5

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.13

1.44

1.0

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.73

1.43

6.3

3.7

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.73

1.43

1.7

1.5

53.2

45.8

umol/l

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

2.04

1.43

1.9

2.5

212.1

179.6

0.22

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

270

1.45

1.42

1.1

128.0

116.8

1.15

248

(44816559) Phosphatidylethanol [Mass/volume] in Blood

329

1.41

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.18

1.40

2.4

2.8

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.08

1.38

6.2

6.8

—

(40757373) Influenza virus identified in Isolate

2.20

1.37

1.1

1.6

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.61

1.36

1.2

2.0

—

(3019174) dRVVT (LA screen)

2.94

1.36

1.0

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

2.94

1.36

1.0

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

2.94

1.36

1.0

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.83

1.35

1.5

1.1

350.7

209.6

iu/ml

0.34

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.15

1.33

1.3

3.6

—

(4198724)

2.04

1.32

1.4

1.8

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

192

1.52

1.32

1.3

1.5

0.3

nmol/l

0.08

145

(3045716) Anion gap in Serum or Plasma

1.74

1.31

1.7

2.8

9.7

mmol/l

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.10

1.30

1.1

—

(3003338) MCHC [Mass/volume]

1673

17209

0.92

1.30

28.8

18.3

331.9

332.5

g/l

1.68

1664

17079

(3016879) Cocaine [Presence] in Urine

421

1.34

1.29

1.6

1.9

—

(3047189) Immunofixation for 24 hour Urine

106

1.70

1.29

1.4

1.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

456

1.32

1.29

5.7

3.4

29.0

26.2

mg/l

0.17

286

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

175

0.51

1.28

1.6

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

192

0.52

1.27

1.4

—

(3051651) Icteric interference index of Serum or Plasma

122

1.64

1.27

3.0

3.8

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.72

1.27

1.0

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.29

1.27

1.0

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

130

1.62

1.26

1.1

1.3

14.4

12.3

mmol/l

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.40

1.24

1.0

1.2

1.8

1.9

umol/24h

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

270

1.41

1.23

4.2

5.6

338.3

367.4

umol/l

0.56

242

(3005570) Glucose [Moles/volume] in Urine

204

1.48

1.22

2.1

2.0

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.63

1.21

1.4

1.2

76.0

133.2

ug/l

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

142

0.49

1.20

1.4

1.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

117

1.63

1.18

1.4

1.8

7.8

12.4

umol/l

0.34

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

240

2125

1.14

1.18

1.5

1.6

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

1.78

1.17

1.9

2.2

156.0

165.9

0.15

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

182

1.49

1.15

1.3

1.7

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.05

1.15

1.0

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

448

1.30

1.14

1.7

1.9

—

(44813793)

119

1.60

1.11

1.0

—

(3005033) Fetal Nuchal fold Thickness US

137

0.51

1.09

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

137

0.51

1.09

1.4

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.38

1.09

2.0

2.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.38

1.09

1.0

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

162

0.55

1.08

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

162

0.55

1.08

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

162

0.55

1.08

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

162

0.55

1.08

1.3

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

118

996

1.19

1.07

1.5

1.6

—

(3000034) Microalbumin [Mass/volume] in Urine

203

1.43

1.05

3.5

3.1

17.1

31.8

mg/l

0.77

154

(3036071) Salmonella sp Ab [Titer] in Serum

1.79

1.04

1.5

1.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

154

1.50

1.03

1.7

1.6

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.28

1.03

1.4

2.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.28

1.03

1.0

1.5

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.28

1.03

1.0

1.5

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.28

1.03

1.0

1.5

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

2.28

1.03

9.4

13.8

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

130

1.54

1.02

1.4

1.2

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

108

0.46

1.00

15.0

13.4

1166.2

849.4

nmol/l

—

102

(3023383) Lactate [Moles/volume] in Pleural fluid

1.77

1.00

1.2

1.5

3.2

3.5

mmol/l

0.11

(3027008) Opiates [Presence] in Urine

449

1.28

0.99

1.6

1.9

—

(3023419) Bacteria identified in Sputum by Culture

274

1.36

0.99

3.3

2.5

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.84

0.98

6.6

7.0

—

(44806420)

1.81

0.98

3.0

2.4

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.95

0.97

7.9

7.0

—

(3045788) Cell count panel - Pleural fluid

211

0.61

0.96

1.8

1.5

—

(3028300) Cannabinoids [Presence] in Urine

452

1.27

0.95

1.7

1.9

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

133

1.51

0.94

1.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.78

0.94

2.1

2.9

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.78

0.94

2.1

2.9

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.89

0.94

1.0

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.89

0.94

1.4

—

(3024263) Appearance of Synovial fluid

117

1.54

0.93

2.2

1.7

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

159

1.45

0.91

1.0

1.2

—

(4094501)

601

1.22

0.89

1.2

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

2.00

0.87

1.0

1.1

—

(21494434) Karyotype in Bone marrow

204

1.38

0.85

1.4

1.2

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

355

0.73

0.84

3.1

3.8

30.2

35.2

u/ml

0.15

344

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.78

0.84

1.3

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

110

949

1.17

0.83

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.74

0.82

1.6

1.3

—

(3027944) Amphetamines [Presence] in Urine

444

1.24

0.82

1.6

1.8

—

(4281824)

213

0.66

0.81

1.1

1.2

—

(3025130) Human papilloma virus identified in Specimen

189

1.38

0.81

2.0

1.8

—

(4306422)

276

1.31

0.80

1.3

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.79

0.0

1.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

278

1.30

0.77

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.76

0.0

1.4

—

(3034426) Prothrombin time (PT)

1.70

0.75

1.3

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.67

0.74

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.67

0.74

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.67

0.74

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.67

0.74

1.0

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

280

1.29

0.74

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

108

1.48

0.73

1.6

2.4

—

(4133840)

1.64

0.73

1.7

1.2

—

(3020650) Glucose [Presence] in Urine

1.64

0.73

1.1

1.6

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

100

1.50

0.72

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.80

0.72

1.0

1.9

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.58

0.71

1.7

1.4

—

(3028717) Thiamine [Mass/volume] in Blood

1.92

0.70

1.2

1.3

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.71

0.70

3.7

1.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.60

0.68

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

118

0.59

0.67

2.1

1.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

102

1.47

0.67

3.8

4.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

168

0.65

0.67

1.3

1.0

—

0.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.79

0.66

1.8

1.5

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

403

1.22

0.65

3.1

3.2

0.8

nmol/l

0.52

312

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

313

1.25

0.65

1.0

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

120

1.42

0.64

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

120

1.42

0.64

1.1

1.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

386

1.22

0.64

1.8

1.6

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.63

0.62

1.4

1.8

—

(1761868) Lipid panel - Serum or Plasma

707

7348

0.95

0.60

3.7

2.9

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.48

0.57

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

158

1.33

0.57

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.43

0.56

1.4

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.54

0.53

1.0

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

134

1.35

0.53

1.9

1.7

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

134

1.35

0.53

1.9

1.7

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

126

1.35

0.51

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.41

0.51

1.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

106

953

1.12

0.50

2.9

3.7

54.6

67.0

u/ml

0.28

101

923

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

288

1.22

0.50

1.4

1.2

2.5

4.5

u/ml

1.06

124

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

663

6397

1.05

0.49

4.1

4.2

21.6

21.5

0.09

300

3122

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.56

0.49

1.0

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

119

1.35

0.48

1.4

1.9

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.43

0.45

2.0

2.4

—

(1002224) Polysomnography panel

837

1.12

0.45

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.40

0.45

1.4

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

175

1.26

0.43

1.3

1.2

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

1.43

0.42

1.6

1.4

36.6

27.9

—

(40758292) HTLV I+II Ab panel - Serum

1.56

0.42

2.0

1.4

—

(3000285) Sodium [Moles/volume] in Blood

1.52

0.41

1.6

1.1

—

(3042517) Benzodiazepines panel - Urine

0.00

0.41

0.0

1.3

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.41

0.0

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

7.5

—

(4268621)

204

1.23

0.40

2.6

2.3

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

186

1742

1.07

0.40

2.6

2.7

65.1

ml/min/173m2

0.00

681

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.40

0.0

6.4

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

0.40

0.0

1.4

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.40

0.0

3.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.39

0.0

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

106

1.32

0.39

1.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

233

1.20

0.38

1.5

1.4

236373.9

100664.1

e6/l

0.54

141

(3038177) Helicobacter pylori Ab [Presence] in Serum

300

1.17

0.36

1.2

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

291

1.17

0.35

1.4

1.2

10.2

4.4

u/ml

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

273

1.17

0.35

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

256

2681

0.95

0.32

1.5

1.4

—

(3017569) Oxygen content in Arterial blood

101

1.29

0.31

1.3

2.6

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.30

0.30

1.1

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

157

1.21

0.29

1.4

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.25

0.29

1.1

1.0

—

(3000492) Spirometry study

210

2004

1.05

0.28

1.4

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.27

0.27

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

233

1.16

0.27

1.4

1.3

7.2

7.4

mmol/l

0.14

171

(3016650) Hepatitis A virus Ab [Presence] in Serum

310

1.13

0.26

1.1

—

(3002256) Pathology report gross observation

289

2793

1.04

0.24

1.4

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

265

0.87

0.24

1.1

0.3

1.8

u/ml

—

109

(3035320) C reactive protein [Mass/volume] in Body fluid

124

1.21

0.24

2.3

2.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

180

1.17

0.23

1.1

—

(40768441) Liver Pathology biopsy report

147

0.82

0.23

1.1

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

106

1.23

0.23

1.4

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

106

1.23

0.23

1.4

1.7

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

588

0.92

0.23

1.3

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

274

0.87

0.22

1.0

1.1

—

(3045142) Bone marrow Pathology biopsy report

257

1.13

0.22

1.8

1.3

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.21

0.0

1.6

—

1.3

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.4

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.1

—

7.7

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.1

—

21.6

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.1

—

8.1

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.1

—

38.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

272

0.88

0.20

1.1

4.9

u/ml

—

130

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

0.20

0.0

2.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

113

0.80

0.20

1.0

1.1

—

(3035880) pH of Pleural fluid

118

1.19

0.19

1.8

1.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.15

0.19

2.0

1.6

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

1.17

0.17

1.7

1.9

6.7

9.1

mg/l

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

484

1.08

0.17

1.3

1.2

168.8

202.3

miu/ml

0.35

206

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

0.71

0.16

1.6

2.3

162.8

151.5

nmol/l

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.18

0.16

2.6

1.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

597

0.94

0.16

1.7

1.8

—

(1617658) Protocol used for examination of sentinel lymph nodes

172

0.87

0.15

1.0

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

143

1481

0.96

0.15

1.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

1.08

0.14

2.7

1.7

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

0.80

0.14

1.0

1.1

—

0.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

275

0.91

0.14

1.0

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

802

1.05

0.14

2.4

3.5

51.4

1952.6

u/ml

0.89

684

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

558

1.06

0.13

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

273

0.91

0.13

1.0

1.1

—

(40768806) Pleura Pathology biopsy report

230

0.91

0.11

2.0

1.6

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

387

1.06

0.10

1.2

57.8

42.7

u/l

0.29

328

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

106

1.13

0.09

1.3

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

546

1.04

0.09

1.4

1.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.08

0.08

1.0

1.6

—

(3033799) Differential panel - Peritoneal fluid

1.04

0.08

1.6

2.4

—

(3015183) Erythrocyte sedimentation rate

101

0.89

0.06

1.1

1.2

—

(44790047)

237

1.06

0.05

1.6

1.5

—

(44790048)

237

1.06

0.05

1.6

1.5

—

(44790049)

237

1.06

0.05

1.6

1.5

—

(44806118)

237

1.06

0.05

1.6

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

718

0.97

0.05

1.5

1.7

4.0

mg/l

0.00

517

(3036782) Glucose [Moles/volume] in Pleural fluid

202

0.94

0.05

1.9

1.5

6.5

mmol/l

0.03

187

(3002385) Erythrocyte distribution width [Ratio]

1701

16973

1.01

0.05

28.7

17.4

13.9

13.7

4.62

1681

16565

(3004716) Salmonella sp identified in Stool by Organism specific culture

943

1.02

0.04

1.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

309

1.04

0.03

1.2

1.1

0.3

1.8

u/ml

—

128

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

142

1.06

0.02

1.3

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

501

1.02

0.02

1.3

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

133

1.05

0.01

1.4

1.3

—

1.5

—

(40768793) Breast Pathology biopsy report

452

1.02

0.01

1.3

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

154

1.04

0.00

1.4

1.5

0.9

1.0

g/l

0.35

154

(3014133) Dog dander IgE Ab [Units/volume] in Serum

204

1.03

0.00

1.1

1.0

2.0

2.6

u/ml

—

(40768795) Lymph node Pathology biopsy report

204

1.03

0.00

1.0

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

105

0.95

0.00

4.4

3.7

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

125

0.96

0.00

3.3

6.7

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

121

0.99

0.00

1.3

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

191

0.99

0.00

1.1

12.7

3.7

u/ml

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

229

1.00

0.00

1.0

1.1

—

(3012441) Differential panel - Pleural fluid

233

0.99

0.00

1.9

1.5

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

147

1.02

0.00

1.7

1.3

14.7

12.2

u/l

0.29

135

(40765096) Chromosome analysis panel by Banding

0.93

0.00

1.3

1.1

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

7.6

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

2.5

—

2.7

—

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3044007) Cell count panel - Peritoneal fluid

0.98

0.00

1.3

2.3

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

0.99

0.00

18.0

12.0

0.7

0.6

mmol/l

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.96

0.00

1.4

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.0

1.3

—

129.3

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

0.86

0.00

1.8

3.2

4.1

7.2

mg/l

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.3

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.0

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.92

0.00

1.2

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

0.00

0.0

1.0

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

0.0

1.2

—

174.4

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.0

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.0

1.1

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

235.5

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

0.00

0.0

5.4

—

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.0

1.1

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

(3022725) Serotonin [Moles/volume] in Serum

0.00

0.0

2.0

—

855.8

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_NEUROOTH and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_NEUROOTH	1.537 [1.37, 1.72]	< 0.001
Birth year	0.994 [0.98, 1.0]	0.136

During the follow-up period (1.1.1998 — 31.12.2019), 1028 out of 5356 females with G6_NEUROOTH died.

Males

Parameter	HR [95% CI]	p-value
G6_NEUROOTH	1.566 [1.4, 1.75]	< 0.001
Birth year	0.985 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 1427 out of 6181 males with G6_NEUROOTH died.

Mortality risk

Mortality risk for people of age

years, who have G6_NEUROOTH.

N-year risk	Females	Males
1	0.143%	0.305%
5	0.884%	1.664%
10	2.071%	4.471%
15	4.006%	8.346%
20	6.955%	13.924%

Relationships between endpoints

↥

Index endpoint: G6_NEUROOTH – Other disorders of nervous system

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other disorders of nervous system

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints